Cobiz Financial (COBZ) 10-Q 27 Oct 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Oct. 25, 2017
Document And Entity Information
Entity Registrant Name	COBIZ FINANCIAL INC
Entity Central Index Key	1,028,734
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,017
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		42,233,365

Condensed Consolidated Financia

Condensed Consolidated Financial Statements - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Assets
Cash and due from banks	$ 60,572	$ 69,333
Interest-bearing deposits and federal funds sold	18,733	26,717
Total cash and cash equivalents	79,305	96,050
Investment securities available for sale (cost of $172,321 and $130,308, respectively)	177,591	132,981
Investment securities held to maturity (fair value of $360,380 and $363,178, respectively)	360,935	366,041
Other investments	11,222	11,365
Total investments	549,748	510,387
Loans - net of allowance for loan losses of $36,850 and $33,293, respectively	3,084,848	2,900,812
Intangible assets - net of amortization of $7,554 and $7,104, respectively	876	1,326
Bank-owned life insurance	54,689	53,674
Premises and equipment - net of depreciation of $36,768 and $38,269, respectively	10,701	11,019
Accrued interest receivable	13,698	12,223
Deferred income taxes, net	20,265	19,901
Other real estate owned - net of valuation allowance of $8,666 and $8,666, respectively	5,079	5,079
Other	17,634	19,842
TOTAL ASSETS	3,836,843	3,630,313
Liabilities
Noninterest-bearing demand	1,373,792	1,282,463
Interest-bearing demand	721,600	714,062
Money market	925,589	861,856
Savings	21,210	19,561
Certificates of deposits	135,341	151,841
Total deposits	3,177,532	3,029,783
Securities sold under agreements to repurchase	60,335	27,639
Other short-term borrowings	101,476	106,230
Accrued interest and other liabilities	37,071	33,074
Subordinated notes payable - net of unamortized discount and issuance costs of $827 and $889, respectively	59,173	59,111
Junior subordinated debentures	72,166	72,166
TOTAL LIABILITIES	3,507,753	3,328,003
Commitments and contingencies
Shareholders' Equity
Preferred stock, $.01 par value; 2,000,000 shares authorized; none issued and outstanding
Common stock, $.01 par value; 100,000,000 shares authorized; 41,799,566 and 41,555,208 issued and outstanding, respectively	414	411
Additional paid-in capital	201,333	197,758
Retained earnings	125,597	103,575
Accumulated other comprehensive income (AOCI), net of income tax of $1,064 and $348, respectively	1,746	566
TOTAL SHAREHOLDERS' EQUITY	329,090	302,310
TOTAL LIABILITIES AND EQUITY	$ 3,836,843	$ 3,630,313

Condensed Consolidated Financi3

Condensed Consolidated Financial Statements (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Condensed Consolidated Financial Statements
Investment securities available for sale, cost	$ 172,321	$ 130,308
Investment securities held to maturity, fair value	360,380	363,178
Allowance for loan losses	36,850	33,293
Intangible assets, amortization	7,554	7,104
Premises and equipment, depreciation	36,768	38,269
Other real estate owned assets, allowance	8,666	8,666
Discount and debt issuance costs	$ 827	$ 889
Preferred, par value	$ 0.01	$ 0.01
Preferred, shares authorized	2,000,000	2,000,000
Preferred, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	41,799,566	41,555,208
Common stock, shares outstanding	41,799,566	41,555,208
Accumulated other comprehensive income, tax	$ 1,064	$ 348

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
INTEREST INCOME:
Interest and fees on loans	$ 33,170	$ 29,124	$ 93,966	$ 85,020
Interest and dividends on investment securities:
Taxable securities	3,361	2,844	10,160	8,870
Nontaxable securities	191	179	572	538
Dividends on securities	156	111	557	473
Interest on federal funds sold and other	69	50	179	102
Total interest income	36,947	32,308	105,434	95,003
INTEREST EXPENSE:
Interest on deposits	1,024	996	2,966	2,840
Interest on short-term borrowings and securities sold under agreements to repurchase	298	60	1,084	470
Interest on subordinated debentures and notes payable	1,856	1,851	5,532	5,530
Total interest expense	3,178	2,907	9,582	8,840
NET INTEREST INCOME BEFORE PROVISION FOR LOAN LOSSES	33,769	29,401	95,852	86,163
Provision for loan losses	1,060	(1,168)	2,340	(2,450)
NET INTEREST INCOME AFTER PROVISION FOR LOAN LOSSES	32,709	30,569	93,512	88,613
NONINTEREST INCOME:
Service charges	1,660	1,553	5,119	4,508
Investment advisory income	1,550	1,416	4,581	4,296
Insurance income	3,338	3,120	9,887	9,282
Other income	2,447	3,197	6,047	6,700
Total noninterest income	8,995	9,286	25,634	24,786
NONINTEREST EXPENSE:
Salaries and employee benefits	18,421	17,480	55,876	53,093
Occupancy expenses, premises and equipment	3,666	4,025	10,956	11,032
Amortization of intangibles	150	150	450	450
FDIC and other assessments	363	369	962	1,297
Other real estate owned and loan workout costs	33	120	215	432
Net (gain) loss on securities, other assets and other real estate owned	6	(98)	(307)	(88)
Other expense	3,753	3,997	12,009	11,927
Total noninterest expense	26,392	26,043	80,161	78,143
INCOME BEFORE INCOME TAXES	15,312	13,812	38,985	35,256
Provision for income taxes	4,119	3,543	9,689	9,090
NET INCOME	$ 11,193	$ 10,269	$ 29,296	$ 26,166
EARNINGS PER COMMON SHARE:
Basic	$ 0.27	$ 0.25	$ 0.70	$ 0.63
Diluted	$ 0.27	$ 0.25	$ 0.70	$ 0.63

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net income	$ 11,193	$ 10,269	$ 29,296	$ 26,166
Cash flow hedges:
Net unrealized gain (loss)	88	507	184	(2,218)
Reclassification to operations	188	275	419	833
Total	276	782	603	(1,385)
Total other comprehensive income (loss) items	(590)	920	1,896	(1,669)
Cash flow hedges:
Net unrealized gain (loss)	34	193	70	(843)
Reclassification to operations	71	105	158	317
Total tax expense (benefit)	105	298	228	(526)
Total income tax provision (benefit)	(223)	350	716	(634)
Other comprehensive income (loss), net of tax	(367)	570	1,180	(1,035)
Comprehensive income	10,826	10,839	30,476	25,131
Available for sale securities
Other comprehensive income (loss) items:
Net unrealized gain (loss)	(399)	695	2,601	1,196
Reclassification to operations	2	(98)	5	(95)
Total	(397)	597	2,606	1,101
Income tax provision:
Net unrealized gain	(151)	263	983	454
Reclassification to operations	1	(37)	2	(36)
Total tax expense (benefit)	(150)	226	985	418
Held to maturity securities
Other comprehensive income (loss) items:
Reclassification to operations	(469)	(459)	(1,313)	(1,385)
Total	(469)	(459)	(1,313)	(1,385)
Income tax provision:
Reclassification to operations	(178)	(174)	(497)	(526)
Total tax expense (benefit)	$ (178)	$ (174)	$ (497)	$ (526)

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 29,296	$ 26,166
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and accretion	4,031	3,319
Provision for loan losses	2,340	(2,450)
Stock-based compensation	2,577	2,492
Deferred income taxes	(1,080)	3,599
Bank-owned life insurance	(1,015)	(1,000)
Net gain on securities, other assets and other real estate owned	(307)	(88)
Other operating activities, net	(1,507)	122
Changes in operating assets and liabilities:
Other assets	3,054	81
Other liabilities	4,416	2,872
Net cash provided by operating activities	41,805	35,113
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of other investments	(19,271)	(11,489)
Proceeds from other investments	20,044	17,487
Purchase of investment securities available for sale	(80,434)	(1,970)
Purchase of investment securities held to maturity	(51,495)	(12,651)
Maturity, call and principal payments on investment securities available for sale		16,251
Maturity, call and principal payments on investment securities held to maturity	90,361	48,253
Purchase of bank-owned life insurance		(3,195)
Net proceeds from sale of loans, OREO and repossessed assets		60
Loan originations and repayments, net	(185,511)	(128,944)
Purchase of premises and equipment	(2,300)	(5,355)
Other investing activities, net	638	272
Net cash used in investing activities	(227,968)	(81,281)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net increase in demand, money market and savings accounts	164,249	194,419
Net increase (decrease) in certificates of deposits	(16,500)	1,062
Net decrease in short-term borrowings	(4,754)	(129,801)
Net increase in securities sold under agreements to repurchase	32,696	4,655
Proceeds from issuance of common stock	1,315	1,342
Taxes paid in net settlement of restricted stock	(1,126)	(890)
Dividends paid on common stock	(6,462)	(5,783)
Net cash provided by financing activities	169,418	65,004
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(16,745)	18,836
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	96,050	67,312
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 79,305	$ 86,148

Nature of Operations and Signif

Nature of Operations and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2017
Nature of Operations and Significant Accounting Policies
Nature Of Operations and Significant Accounting Policies	1. Nature of Operations and Significant Accounting Policies The accompanying unaudited Condensed Consolidated Financial Statements of CoBiz Financial Inc. (Parent or Holding Company), and its wholly-owned subsidiaries: CoBiz Bank (Bank); CoBiz Insurance, Inc.; and CoBiz IM, Inc. (CoBiz IM); all collectively referred to as the “Company”, “CoBiz”, “we”, “us”, or “our” conform to Generally Accepted Accounting Principles (GAAP) in the United States of America for interim financial information and prevailing practices within the banking industry. The operations of the Company are comprised predominantly of the Bank, which operates in its Colorado market areas under the name Colorado Business Bank (CBB) and in its Arizona market areas under the name Arizona Business Bank (ABB). Organization — The Bank is a commercial banking institution with seven locations in the Denver metropolitan area; one in Boulder; one near Vail; one in Colorado Springs; one in Fort Collins; and four in the Phoenix metropolitan area. As a state chartered bank, deposits are insured by the Bank Insurance Fund of the Federal Deposit Insurance Corporation (the FDIC) and the Bank is subject to supervision, regulation and examination by the Federal Reserve System (Federal Reserve), Colorado Division of Banking and the FDIC. Pursuant to such regulations, the Bank is subject to special restrictions, supervisory requirements and potential enforcement actions. CoBiz Insurance, Inc. provides commercial and personal property and casualty (P&C) insurance brokerage, risk management consulting services to small and medium-sized businesses and individuals and provides employee benefits consulting, insurance brokerage and related administrative support to employers. CoBiz IM provides wealth planning and investment management to institutions and individuals through its SEC-registered investment advisor subsidiary, CoBiz Wealth, LLC. The following is a summary of certain of the Company’s significant accounting and reporting policies. Basis of Presentation — The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Form 10-Q and, where applicable, prevailing practices within the financial services industry. The December 31, 2016 Condensed Consolidated balance sheet has been derived from the audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2016. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting only of normally recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2017, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017. In preparing its financial statements, the Company is required to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. These Condensed Consolidated Financial Statements and notes thereto should be read in conjunction with, and are qualified in their entirety by, the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, as filed with the U.S. Securities and Exchange Commission (SEC). The Condensed Consolidated Financial Statements include entities in which the Parent has a controlling financial interest. These entities include: the Bank; CoBiz Insurance, Inc.; and CoBiz IM. Intercompany balances and transactions are eliminated in consolidation. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity (VIE). The voting interest model is used when the equity investment is sufficient to absorb the expected losses and the equity investment has all of the characteristics of a controlling financial interest. Under the voting interest model, the party with the controlling voting interest consolidates the legal entity. The VIE model is used when any of the following conditions exist: the equity investment at risk is not sufficient to finance the entity’s activities without additional subordinated financial support; the holders of the equity investment do not have a controlling voting interest; or the holders of the equity investment are not obligated to absorb the expected losses or residual returns of the legal entity. An enterprise is considered to have a controlling financial interest of a VIE if it has both the power to direct the activities that most significantly impact economic performance and the obligation to absorb losses, or receive benefits, that are significant to the VIE. An enterprise that has a controlling financial interest is considered the primary beneficiary and must consolidate the VIE. The Company was not the primary beneficiary of a VIE at September 30, 2017 or December 31, 2016. Certain reclassifications have been made to prior years’ Condensed Consolidated Financial Statements and related notes to conform to the current year presentation. Cash and Cash Equivalents — The Company considers all liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include amounts that the Company is required to maintain at the Federal Reserve Bank of Kansas City to meet certain regulatory reserve balance requirements. The following table shows supplemental disclosures of certain cash and noncash items: Nine months ended September 30, (in thousands) 2017 2016 Cash paid during the period for: Interest $ 8,745 $ 8,141 Income taxes 8,112 5,538 Other noncash activities: Loans transferred to held for sale $ - $ 60 Lessor-paid tenant improvement allowance 358 - Investments — The Company classifies its investment securities as held to maturity, available for sale or trading, according to management’s intent. Investment security transactions are recorded on a trade date basis. At September 30, 2017 and December 31, 2016, the Company had no trading securities. Available for sale securities consist of bonds, notes and debentures (including corporate debt and trust preferred securities (TPS)) not classified as held to maturity securities and are reported at fair value as determined by quoted market prices. Unrealized holding gains and losses, net of tax, are reported as a net amount in AOCI until realized. Investment securities held to maturity consist of residential mortgage-backed securities (MBS), bonds, notes and debentures for which the Company has the positive intent and ability to hold to maturity and are reported at cost, adjusted for amortization or accretion of premiums and discounts. Premiums and discounts, adjusted for prepayments as applicable, are recognized in interest income. Other than temporary declines in the fair value of individual investment securities held to maturity and available for sale are charged against earnings. Gains and losses on disposal of investment securities are determined using the specific-identification method. Other-than-temporary-impairment (OTTI) on debt securities is separated between the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income (OCI). Bank Stocks — Federal Home Loan Bank of Topeka (FHLB), Federal Reserve Bank and other correspondent bank stocks are accounted for under the cost method. Loans Held for Investment — Loans that the Company has the intent and ability to hold for the foreseeable future or until maturity or pay-off are reported at their outstanding principal balance adjusted for any charge-offs, the allowance for loan losses, deferred fees and costs on originated loans, and unamortized premiums or discounts on purchased loans. Interest is accrued and credited to income daily based on the principal balance outstanding. Loans that are 30 days or more past due based on payments received and applied to the loan are considered delinquent, excluding loans that are cash-secured. The accrual of interest income is generally discontinued when a loan becomes 90 days past due as to principal and interest. When a loan is designated as nonaccrual, the current period’s accrued interest receivable is charged against current earnings while any portions relating to prior periods are charged against the allowance for loan losses. Interest payments received on nonaccrual loans are generally applied to the principal balance of the loan. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured and there has been demonstrated performance in accordance with contractual terms. The Company may elect to continue the accrual of interest when the loan is in the process of collection and the realizable value of collateral is sufficient to cover the principal balance and accrued interest. Loans Held for Sale — Loans held for sale include loans the Company has demonstrated its ability and intent to sell. Loans held for sale are primarily nonperforming loans. Loans held for sale are carried at the lower of cost or fair value and are evaluated on a loan-by-loan basis. Impaired Loans — Impaired loans, with the exception of groups of smaller-balance homogenous loans that are collectively evaluated for impairment, are defined as loans for which, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays of less than 90 days and monthly payment shortfalls of less than 10% of the contractual payment on a consumer loan generally are not classified as impaired if the Company ultimately expects to recover its full investment. The Company determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Loans that are deemed to be impaired are evaluated in accordance with Accounting Standards Codification (ASC) Topic 310-10-35, Receivables – Subsequent Measurement (ASC 310) and ASC Topic 450-20, Loss Contingencies (ASC 450). Included in impaired loans are troubled debt restructurings. A troubled debt restructuring is a formal restructure of a loan where the Company, for economic or legal reasons related to the borrower’s financial difficulties, grants a concession to the borrower. The concessions may be granted in various forms, including but not limited to reduction in the stated interest rate, reduction in the loan balance or accrued interest, or extension of the maturity date. Troubled debt restructurings are evaluated in accordance with ASC Topic 310-40, Troubled Debt Restructurings by Creditors. Interest payments on impaired loans are typically applied to principal unless collectability of principal is reasonably assured. Loans that have been modified in a formal restructuring are typically returned to accrual status when there has been a sustained period of performance (generally six months) under the modified terms, the borrower has shown the ability and willingness to repay and the Company expects to collect all amounts due under the modified terms. Loan Origination Fees and Costs — Loan fees and certain costs of originating loans are deferred and the net amount is amortized over the contractual life of the related loans in accordance with ASC Topic 310-20, Nonrefundable Fees and Other Costs. Allowance for Loan Losses — The allowance for loan losses (ALL) is established as losses are estimated to have occurred through a provision for loan losses charged against earnings. Loan losses are charged against the ALL when management believes the uncollectability of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the ALL. The ALL is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral, and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as new information becomes available. Allowance for Credit Losses — The allowance for credit losses is established as losses are estimated to have occurred through a provision for credit losses charged to earnings. The allowance for credit losses represents management’s recognition of a separate reserve for off-balance sheet loan commitments and letters of credit. While the allowance for loan losses is recorded as a contra-asset to the loan portfolio on the Condensed Consolidated Balance Sheets, the allowance for credit losses is recorded under the caption “Accrued interest and other liabilities”. Although the allowances are presented separately on the balance sheets, any losses incurred from credit losses would be reported as a charge-off in the allowance for loan losses, as any loss would be recorded after the off-balance sheet commitment had been funded. Bank-Owned Life Insurance (BOLI) – The Bank has invested in BOLI policies to fund certain future employee benefit costs. The policies are recorded at net realizable value. Changes in the amount that could be realized, including death benefits in excess of the carrying amount, are recorded in the Condensed Consolidated Statements of Income as “Other income”. Derivative Instruments — Derivative financial instruments are accounted for at fair value. The Company utilizes interest rate swaps to hedge a portion of its exposure to interest rate changes. These instruments are accounted for as cash flow hedges, as defined by ASC Topic 815, Derivatives and Hedging (ASC 815). The Company also uses interest rate swaps to hedge against adverse changes in fair value on fixed-rate loans. These instruments are accounted for as fair value hedges in accordance with ASC 815. The net cash flows from the cash flow and fair value hedges are classified in operating activities within the Condensed Consolidated Statements of Cash Flows with the hedged items. The Company also offers an interest-rate hedge program that includes various derivative products, including swaps, to customers of the Bank. The fair value amounts recognized for derivative instruments and the fair value amounts recognized for the right to reclaim or obligation to return cash collateral are not offset when represented under a master netting arrangement. The Company also uses foreign currency forward contracts (FX forwards) giving it the right to sell underlying currencies at specified future dates and predetermined prices in order to mitigate foreign exchange risk associated with long positions. FX forwards are carried at fair value with changes in value recognized in current earnings as the contracts are not designated as hedging instruments. Fair Value Measurements — The Company measures financial assets, financial liabilities, nonfinancial assets and nonfinancial liabilities pursuant to ASC Topic 820, Fair Value Measurement and Disclosures (ASC 820). ASC 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. Warrant — The Company issued a warrant on December 19, 2008 as part of the Company’s participation in the federal Troubled Asset Relief Plan (TARP) Capital Purchase Program under the Emergency Economic Stabilization Act of 2008. The warrant had a 10-year term and allowed for the purchase of 895,968 shares of the Company’s common stock at an exercise price of $10.79 per share. On October 20, 2017 the warrant was exercised in a cashless transaction and the Company issued 432,299 shares of common stock in full settlement of the warrant.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2017
Recent Accounting Pronouncements
Recent Accounting Pronouncements	2. Recent Accounting Pronouncements In May 2014, the Financial Accounting Standard Board (FASB) issued Accounting Standard Update (ASU) 2014-9 (ASU 2014-09), Revenue from Contracts with Customers. The core principle of ASU 2014-09 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also specifies the accounting for some costs to obtain or fulfill a contract with a customer, as well as enhanced disclosure requirements. In August 2015, the FASB issued ASU 2015-14 which deferred the effective date of ASU 2014-09 to fiscal years, and interim reporting periods within those fiscal years, beginning after December 15, 2017. In March 2016, the FASB issued ASU 2016-08 which clarified the revenue recognition implementation guidance on principal versus agent considerations and is effective during the same period as ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation and is effective during the same period as ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU 2016-12 is effective during the same period as ASU 2014-09. Although the Company is still evaluating the effects of these ASUs on its financial statements and disclosures, the Company has determined the following: · The Company has conducted its scoping assessment and is currently evaluating contracts to assess and quantify accounting methodology changes resulting from the adoption of ASU 2014-09. · The Company expects these ASUs to have more of an impact on the Fee-Based Lines segment than the Commercial Banking segment, which generates the majority of the Company’s revenue. Revenue from the Fee-Based Lines segment includes property and casualty brokerage income, employee benefit brokerage income and investment advisory income which totaled $18.3 million in 2016. · The Company will adopt ASU 2014-09 using the modified retrospective method on January 1, 2018. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (ASU 2016-02). ASU 2016-02 is intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about lease arrangements. For public business entities, this ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018. The Company is currently evaluating the effects of ASU 2016-02 on its financial statements and disclosures by reviewing all existing lease arrangements. Preliminarily, the Company expects the primary impact of ASU 2016-02 will relate to its office locations, which are designated as operating leases. The Company has future operating lease obligations for its locations of $30.4 million that are being evaluated as potential lease assets and liabilities, as defined in ASU 2016-02. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13). The objective of ASU 2016-13 is to provide financial statement users with decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit. ASU 2016-13 includes provisions that require financial assets measured at amortized cost (such as loans and held to maturity (HTM) debt securities) to be presented at the net amount expected to be collected. This will be accomplished through recognition of an estimate of all current expected credit losses. The estimate will include forecasted information for the timeframe that an entity is able to develop reasonable and supportable forecasts. This is a change from the current practice of recognizing incurred losses based on the probable initial recognition threshold under current GAAP. In addition, credit losses on available for sale (AFS) debt securities will be recorded through an allowance for credit losses rather than as a write-down. Under ASU 2016-13, an entity will be able to record reversals of credit losses in current period income when the estimate of credit losses declines, whereas current GAAP prohibits reflecting those improvements in current period earnings. ASU 2016-13 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2019, and early adoption is permitted for fiscal years, including interim periods, beginning after December 15, 2018. ASU 2016-13 will be applied through a cumulative effect adjustment to retained earnings (modified-retrospective approach), except for debt securities for which an other-than-temporary impairment had been recognized before the effective date. A prospective transition approach is required for these debt securities. The Company is currently evaluating the effects of ASU 2016-13 on its financial statements and disclosures, including software solutions, data requirements and loss estimation methodologies. While the effects cannot yet be quantified, the Company expects ASU 2016-13 to add complexity and costs to its current credit loss evaluation process. In February 2017, the FASB issued ASU 2017-05, Other Income – Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20) (ASU 2017-05). ASU 2017-05 is intended to clarify that Subtopic 610-20 applies to the derecognition of nonfinancial assets and in substance nonfinancial assets unless other specific guidance applies. ASU 2017-05 also adds guidance for partial sales of nonfinancial assets and eliminates rules specifically addressing sales of real estate. For public business entities, this ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2017. The Company is currently evaluating the effects of ASU 2017-05 on its financial statements and disclosures. In March 2017, the FASB issued ASU 2017-08, Receivables – Nonrefundable Fees and Other Costs (Subtopic 310-20) (ASU 2017-08). ASU 2017-08 amends the amortization period for certain purchased callable debt securities held at a premium. Prior to the issuance of this guidance, premiums were amortized as an adjustment of yield over the contractual life of the instrument. ASU 2017-08 requires premiums on purchased callable debt securities that have explicit, noncontingent call features that are callable at fixed prices to be amortized to the earliest call date. There are no accounting changes for securities held at a discount. This ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018, and early adoption is permitted. ASU 2017-08 will be applied through a cumulative effect adjustment through equity (modified-retrospective approach). The Company is currently evaluating the effects of ASU 2017-08 on its financial statements and disclosures. In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718), Scope of Modification Accounting (ASU 2017-09). ASU 2017-09 clarifies when changes to the terms and conditions of share-based payment awards must be treated as modifications. Specifically, the new guidance permits companies to make certain changes to awards without accounting for them as modifications. ASU 2017-09 is effective for annual periods beginning after December 31, 2017 and will be applied prospectively to an award modified after the effective date. The Company is currently evaluating the effects of ASU 2017-09 on its financial statements and disclosures. In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (ASU 2017-12). The purpose of this updated guidance is to better align a company’s financial reporting for hedging activities with the economic objectives of those activities. ASU 2017-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018, and early adoption is permitted. ASU 2017-12 requires the modified-retrospective approach for adoption. The Company is currently evaluating the effects of ASU 2017-12 on its financial statements and disclosures and is considering early adoption in 2018.

Earnings per Common Share and D

Earnings per Common Share and Dividends Declared per Common Share	9 Months Ended
	Sep. 30, 2017
Earnings per Common Share and Dividends Declared per Common Share
Earnings per Common Share and Dividends Declared per Common Share	3. Earnings per Common Share and Dividends Declared per Common Share Earnings per common share is calculated based on the two-class method prescribed in ASC 260, Earnings per Share. The two-class method is an allocation of undistributed earnings to common stock and securities that participate in dividends with common stock. The Company’s restricted stock awards are considered participating securities since the recipients receive non-forfeitable dividends on unvested awards. The impact of participating securities is included in basic earnings per common share for the three and nine months ended September 30, 2017 and 2016. Income allocated to common shares and weighted average shares outstanding used in the calculation of basic and diluted earnings per common share are as follows: Three months ended Nine months ended September 30, September 30, (in thousands, except share and per share amounts) 2017 2016 2017 2016 Net income available to common shareholders $ 11,193 $ 10,269 $ 29,296 $ 26,166 Dividends and undistributed earnings allocated to participating securities (109) (116) (296) (300) Earnings allocated to common shares (1) $ 11,084 $ 10,153 $ 29,000 $ 25,866 Weighted average common shares - issued 41,783,604 41,434,195 41,713,831 41,334,632 Average unvested restricted share awards (406,406) (462,927) (421,174) (472,885) Weighted average common shares outstanding - basic 41,377,198 40,971,268 41,292,657 40,861,747 Dilutive potential common shares 404,218 220,779 400,977 180,676 Weighted average common shares outstanding - diluted 41,781,416 41,192,047 41,693,634 41,042,423 Weighted average antidilutive securities outstanding (2) 41,101 118,596 27,336 158,154 Earnings per common share: Basic $ 0.27 $ 0.25 $ 0.70 $ 0.63 Diluted $ 0.27 $ 0.25 $ 0.70 $ 0.63 Dividends declared per share $ 0.055 $ 0.050 $ 0.155 $ 0.140 (1) Earnings allocated to common shareholders for basic earnings per common share under the two-class method may differ from earnings allocated for diluted earnings per common share when use of the treasury method results in greater dilution than the two-class method. (2) Antidilutive shares excluded from the diluted earnings per common share computation.

Investments

Investments	9 Months Ended
	Sep. 30, 2017
Investments
Investments	4. Investments The amortized cost and estimated fair values of investment securities are summarized as follows: At September 30, 2017 At December 31, 2016 Gross Gross Gross Gross Amortized unrealized unrealized Fair Amortized unrealized unrealized Fair (in thousands) cost gains losses value cost gains losses value Available for sale securities (AFS): Trust preferred securities $ 35,607 $ 3,464 $ 380 $ 38,691 $ 36,450 $ 1,707 $ 533 $ 37,624 Corporate debt securities 133,460 2,142 12 135,590 90,593 1,505 21 92,077 Municipal securities 3,254 60 4 3,310 3,265 33 18 3,280 Total AFS $ 172,321 $ 5,666 $ 396 $ 177,591 $ 130,308 $ 3,245 $ 572 $ 132,981 Held to maturity securities (HTM): Mortgage-backed securities $ 315,135 $ 466 $ 1,474 $ 314,127 $ 319,978 $ 186 $ 2,531 $ 317,633 Trust preferred securities 10,695 495 326 10,864 10,620 522 267 10,875 Municipal securities 35,105 288 4 35,389 35,443 10 783 34,670 Total HTM $ 360,935 $ 1,249 $ 1,804 $ 360,380 $ 366,041 $ 718 $ 3,581 $ 363,178 The amortized cost and estimated fair value of investments in debt securities at September 30, 2017, by contractual maturity are shown below. Expected maturities can differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties. Available for sale Held to maturity Amortized Fair Amortized Fair (in thousands) cost value cost value Due in one year or less $ 13,456 $ 13,613 $ 867 $ 867 Due after one year through five years 105,969 107,783 24,732 24,978 Due after five years through ten years 23,056 23,813 1,023 1,049 Due after ten years 29,840 32,382 19,178 19,359 Mortgage-backed securities - - 315,135 314,127 $ 172,321 $ 177,591 $ 360,935 $ 360,380 The Company uses investment securities to collateralize public and governmental deposits. Investment securities with an approximate fair value of $175.2 million and $143.6 million were pledged to secure these deposits of $129.9 million and $95.8 million at September 30, 2017 and December 31, 2016, respectively. Changes in interest rates and market liquidity may cause adverse fluctuations in the market price of securities resulting in temporary unrealized losses. In reviewing the realizable value of its securities in a loss position, the Company considered the following factors: (1) the length of time and extent to which the market had been less than cost; (2) the financial condition and near-term prospects of the issuer; (3) investment downgrades by rating agencies; and (4) whether it is more likely than not that the Company will have to sell the security before a recovery in value. When it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the security, and the fair value of the investment security is less than its amortized cost, an other-than-temporary impairment is recognized in earnings. For debt securities that are considered other-than-temporarily impaired and that the Company does not intend to sell and will not be required to sell prior to recovery of the amortized cost basis, an OTTI is recognized. OTTI is separated into the amount that is credit-related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income. The Company did not have any credit impaired securities at September 30, 2017 and December 31, 2016. There were 130 and 165 securities in the tables below at September 30, 2017 and December 31, 2016, respectively, in an unrealized loss position. September 30, 2017 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ 716 $ 25 $ 6,829 $ 355 $ 7,545 $ 380 Corporate debt securities 4,612 12 - - 4,612 12 Municipal securities 839 4 - - 839 4 Total AFS $ 6,167 $ 41 $ 6,829 $ 355 $ 12,996 $ 396 HTM Mortgage-backed securities $ 113,570 $ 698 $ 69,354 $ 776 $ 182,924 $ 1,474 Trust preferred securities - - 4,845 326 4,845 326 Municipal securities 3,547 4 - - 3,547 4 Total HTM $ 117,117 $ 702 $ 74,199 $ 1,102 $ 191,316 $ 1,804 December 31, 2016 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ 14,979 $ 526 $ 995 $ 7 $ 15,974 $ 533 Corporate debt securities 14,482 21 - - 14,482 21 Municipal securities 1,214 18 - - 1,214 18 Total AFS $ 30,675 $ 565 $ 995 $ 7 $ 31,670 $ 572 HTM Mortgage-backed securities $ 217,604 $ 2,107 $ 52,332 $ 424 $ 269,936 $ 2,531 Trust preferred securities 4,175 94 700 173 4,875 267 Municipal securities 30,207 783 - - 30,207 783 Total HTM $ 251,986 $ 2,984 $ 53,032 $ 597 $ 305,018 $ 3,581 Other investments at September 30, 2017 and December 31, 2016, consisted of the following: September 30, December 31, (in thousands) 2017 2016 Bank stocks — at cost $ 9,048 $ 9,192 Investment in statutory trusts — equity method 2,174 2,173 Total $ 11,222 $ 11,365 Bank stocks consist primarily of stock in the FHLB, which is part of the Federal Home Loan Bank System (FHLB System). The purpose of the FHLB investment relates to maintenance of a borrowing base with the FHLB. FHLB stock holdings are largely dependent upon the Company’s liquidity position. To the extent the need for wholesale funding increases or decreases, the Company may purchase additional or sell excess FHLB stock, respectively. The Company evaluates impairment in this investment based on the ultimate recoverability of the par value. At September 30, 2017, the Company did not consider the investment to be other-than-temporarily impaired.

Loans

Loans	9 Months Ended
	Sep. 30, 2017
Loans
Loans	5. Loans The following disclosure reports the Company’s loan portfolio segments and classes. Segments are groupings of similar loans at a level which the Company has adopted systematic methods of documentation for determining its allowance for loan and credit losses. Classes are a disaggregation of the portfolio segments. The Company’s loan portfolio segments are: · Commercial loans – Commercial loans consist of loans to small and medium-sized businesses in a wide variety of industries. The Bank’s areas of emphasis in commercial lending include, but are not limited to, loans to wholesalers, manufacturers, municipalities, construction and business services companies. Commercial loans are generally collateralized by inventory, accounts receivable, equipment, real estate and other commercial assets, and may be supported by other credit enhancements such as personal guarantees. Risk arises primarily due to a difference between expected and actual cash flows of the borrowers. However, the recoverability of the Company’s investment in these loans is also dependent on other factors primarily dictated by the type of collateral securing these loans. The fair value of the collateral securing these loans may fluctuate as market conditions change. In the case of loans secured by accounts receivable, the recovery of the Company’s investment is dependent upon the borrowers’ ability to collect amounts due from its customers. · Real estate - mortgage loans – Real estate mortgage loans include various types of loans for which the Company holds real property as collateral. Commercial real estate lending activity is typically restricted to owner-occupied properties or to investor properties that are owned by customers with a current banking relationship. The primary risks of real estate mortgage loans include the borrower’s inability to pay, material decreases in the value of the real estate that is being held as collateral and significant increases in interest rates, which may make the real estate mortgage loan unprofitable. Real estate loans may be more adversely affected by conditions in the real estate markets or in the general economy. · Construction and land loans – The Company originates loans to finance construction projects including one- to four-family residences, multifamily residences, commercial office, senior housing, and industrial projects. Residential construction loans are due upon the sale of the completed project and are generally collateralized by first liens on the real estate and have floating interest rates. Construction loans are considered to have higher risks due to construction completion and timing risk, and the ultimate repayment being sensitive to interest rate changes, governmental regulation of real property and the availability of long-term financing. Additionally, economic conditions may impact the Company’s ability to recover its investment in construction loans. Adverse economic conditions may negatively impact the real estate market which could affect the borrowers’ ability to complete and sell the project. Additionally, the fair value of the underlying collateral may fluctuate as market conditions change. The Company also originates loans for the acquisition and future development of land for residential building projects, as well as finished lots prepared to enter the construction phase. The primary risks include the borrower’s inability to pay and the inability of the Company to recover its investment due to a decline in the fair value of the underlying collateral. · Consumer loans – The Company provides a broad range of consumer loans to customers, including personal lines of credit, home equity loans, mortgage loans and automobile loans. Repayment of these loans is dependent on the borrowers’ ability to pay and the fair value of the underlying collateral. · Other loans – Other loans include lending products, such as taxable and tax exempt leasing, not defined as commercial, real estate, acquisition and development, construction, or consumer loans. The loan portfolio segments at September 30, 2017 and December 31, 2016 were as follows: (in thousands) At September 30, 2017 At December 31, 2016 Commercial $ 1,250,257 $ 1,217,001 Real estate - mortgage 1,259,648 1,171,596 Construction & land 216,737 175,738 Consumer 287,245 266,947 Other 108,437 103,616 Loans held for investment 3,122,324 2,934,898 Allowance for loan losses (36,850) (33,293) Unearned net loan fees (626) (793) Total net loans $ 3,084,848 $ 2,900,812 The Company maintains a loan review program independent of the lending function that is designed to reduce and control risk in lending. It includes the continuous monitoring of lending activities with respect to underwriting and processing new loans, preventing insider abuse and timely follow-up and corrective action for loans showing signs of deterioration in quality. The Company also has a systematic process to evaluate individual loans and pools of loans within our loan portfolio. The Company maintains a loan grading system whereby each loan is assigned a grade between 1 and 8, with 1 representing the highest quality credit, 7 representing a nonaccrual loan where collection or liquidation in full is highly questionable and improbable, and 8 representing a loss that has been or will be charged-off. Grades are assigned based upon the degree of risk associated with repayment of a loan in the normal course of business pursuant to the original terms. Loans that are graded 5 or lower are categorized as non-classified credits while loans graded 6 and higher are categorized as classified credits. Loan grade changes are evaluated on a monthly basis. Loans above a certain dollar amount that are adversely graded are reported to the Special Assets Group Manager and the Chief Credit Officer along with current financial information, a collateral analysis and an action plan. The loan portfolio showing total non-classified and classified balances by loan class at September 30, 2017 and December 31, 2016 is summarized below: At September 30, 2017 (in thousands) Non-classified Classified Total Commercial Manufacturing $ 88,605 $ 1,369 $ 89,974 Finance and insurance 39,481 475 39,956 Healthcare 150,731 1,954 152,685 Real estate services 117,358 3,456 120,814 Construction 66,868 539 67,407 Public administration 248,957 913 249,870 Other 493,891 35,660 529,551 1,205,891 44,366 1,250,257 Real estate - mortgage Residential & commercial owner-occupied 467,876 6,470 474,346 Residential & commercial investor 784,663 639 785,302 1,252,539 7,109 1,259,648 Construction & land 216,737 - 216,737 Consumer 285,859 1,386 287,245 Other 106,943 1,494 108,437 Total loans held for investment $ 3,067,969 $ 54,355 $ 3,122,324 Unearned net loan fees (626) Net loans held for investment $ 3,121,698 At December 31, 2016 (in thousands) Non-classified Classified Total Commercial Manufacturing $ 96,465 $ 153 $ 96,618 Finance and insurance 49,764 587 50,351 Healthcare 153,468 555 154,023 Real estate services 125,531 513 126,044 Construction 55,471 3,247 58,718 Public administration 254,861 1,136 255,997 Other 437,219 38,031 475,250 1,172,779 44,222 1,217,001 Real estate - mortgage Residential & commercial owner-occupied 469,027 6,496 475,523 Residential & commercial investor 695,170 903 696,073 1,164,197 7,399 1,171,596 Construction & land 172,816 2,922 175,738 Consumer 265,307 1,640 266,947 Other 101,894 1,722 103,616 Total loans held for investment $ 2,876,993 $ 57,905 $ 2,934,898 Unearned net loan fees (793) Net loans held for investment $ 2,934,105 Transactions in the allowance for loan losses by segment for the three and nine months ended September 30, 2017 and 2016 are summarized below: Three months ended September 30, Nine months ended September 30, (in thousands) 2017 2016 2017 2016 Allowance for loan losses, beginning of period Commercial $ 15,749 $ 17,349 $ 15,398 $ 24,215 Real estate - mortgage 12,804 10,281 11,475 10,372 Construction & land 2,484 2,335 1,997 2,111 Consumer 2,561 2,660 2,803 2,592 Other 1,021 786 945 643 Unallocated 1,006 933 675 753 Total 35,625 34,344 33,293 40,686 Provision Commercial $ 437 $ (1,247) $ 829 $ (2,306) Real estate - mortgage (167) 247 998 138 Construction & land 958 (250) 437 (765) Consumer (9) 109 (172) 187 Other (40) 119 36 262 Unallocated (119) (146) 212 34 Total 1,060 (1,168) 2,340 (2,450) Charge-offs Commercial $ - $ (227) $ (222) $ (6,630) Consumer (11) - (97) (20) Other - (4) - (4) Total (11) (231) (319) (6,654) Recoveries Commercial $ 165 $ 460 $ 346 $ 1,056 Real estate - mortgage 3 9 167 27 Construction & land 4 101 1,012 840 Consumer 4 14 11 24 Total 176 584 1,536 1,947 Allowance for loan losses, end of period Commercial $ 16,351 $ 16,335 $ 16,351 $ 16,335 Real estate - mortgage 12,640 10,537 12,640 10,537 Construction & land 3,446 2,186 3,446 2,186 Consumer 2,545 2,783 2,545 2,783 Other 981 901 981 901 Unallocated 887 787 887 787 Total $ 36,850 $ 33,529 $ 36,850 $ 33,529 The Company estimates the ALL in accordance with ASC 310 for purposes of evaluating loan impairment on a loan-by-loan basis and ASC 450 for purposes of collectively evaluating loan impairment by grouping loans with common risk characteristics (i.e. risk classification, past-due status, type of loan, and collateral). The ALL is comprised of the following components: · Specific Reserves – The Company continuously evaluates its reserve for loan losses to maintain an adequate level to absorb loan losses incurred in the loan portfolio. Reserves on loans identified as impaired, including troubled debt restructurings, are based on discounted expected cash flows using the loan’s initial effective interest rate, the observable market value of the loan or the fair value of the collateral for certain collateral-dependent loans. The fair value of the collateral is determined in accordance with ASC 820. Loans are considered to be impaired in accordance with the provisions of ASC 310 when it is probable that all amounts due in accordance with the contractual terms will not be collected. Factors contributing to the determination of specific reserves include the financial condition of the borrower, changes in the value of pledged collateral and general economic conditions. Troubled debt restructurings meet the definition of an impaired loan under ASC 310 and therefore, troubled debt restructurings are subject to impairment evaluation on a loan-by-loan basis. For collateral dependent loans that have been specifically identified as impaired, the Company measures fair value based on third-party appraisals, adjusted for estimated costs to sell the property. Upon impairment, the Company will obtain a new appraisal if one had not been previously obtained in the last 12 months. For credits over $2.0 million, the Company engages an additional third-party appraiser to review the appraisal. For credits under $2.0 million, the Company’s internal appraisal department reviews the appraisal. All appraisals are reviewed for reasonableness based on recent sales transactions that may have occurred subsequent to or at the time of the appraisal. Based on this analysis, the appraised value may be adjusted downward if there is evidence that the appraised value may not be indicative of fair value. Each appraisal is updated on an annual basis, either through a new appraisal or through the Company’s comprehensive internal review process. Values are reviewed and monitored internally and fair value is re-assessed at least quarterly or more frequently when events or circumstances occur that indicate a change in fair value. · General Reserves – General reserves are considered part of the allocated portion of the ALL. The Company uses a comprehensive loan grading process for its loan portfolios. Based on this process, a loss factor is assigned to each pool of graded loans. A combination of loss experience and external loss data is used in determining the appropriate loss factor. This estimate represents the probable incurred losses within the portfolio. In evaluating the adequacy of the ALL, management considers historical losses (Migration), as well as other factors including changes in: · Lending policies and procedures · National and local economic and business conditions and developments · Nature and volume of portfolio · Trends of the volume and severity of past-due and classified loans · Trends in the volume of nonaccrual loans, troubled debt restructurings, and other loan modifications · Credit concentrations Troubled debt restructurings have a direct impact on the ALL to the extent a loss has been recognized in relation to the loan modified. This is consistent with the Company’s consideration of Migration in determining general reserves. The aforementioned factors enable management to recognize environmental conditions contributing to incurred losses in the portfolio, which have not yet manifested in Migration. Management believes Migration history adequately captures a substantial percentage of probable incurred losses within the portfolio. In addition to the allocated reserve for graded loans, a portion of the ALL is determined by segmenting the portfolio into product groupings with similar risk characteristics. Part of the segmentation involves assigning increased reserve factors to those lending activities deemed higher-risk, such as leverage-financings, unsecured loans, certain loans lacking personal guarantees, senior housing, speculative residential construction and multifamily loans. · Unallocated Reserves – The unallocated reserve, which is judgmentally determined, is maintained to recognize the imprecision in estimating and measuring loss when evaluating reserves for individual loans or pools of loans. The unallocated reserve consists of a missed grade component that is intended to capture the inherent risk that certain loans may be assigned an incorrect loan grade. In assessing the reasonableness of management’s assumptions, consideration is given to select peer ratios, industry standards and directional consistency of the ALL. Ratio analysis highlights divergent trends in the relationship of the ALL to nonaccrual loans, to total loans and to historical charge-offs. Although these comparisons can be helpful as a supplement to assess reasonableness of management assumptions, they are not, by themselves, sufficient basis for determining the adequacy of the ALL. While management utilizes its best judgment and information available, the ultimate adequacy of the allowance is dependent upon a variety of factors beyond the Company’s control, including the performance of the loan portfolio, the economy, changes in interest rates and the view of the regulatory authorities toward loan classifications. The following table summarizes loans held for investment and the allowance for loan losses on the basis of the impairment method: At September 30, 2017 At December 31, 2016 Individually evaluated for impairment Collectively evaluated for impairment Individually evaluated for impairment Collectively evaluated for impairment (in thousands) Loans Allowance Loans Allowance Loans Allowance Loans Allowance Commercial $ 33,585 $ 3,362 $ 1,218,230 $ 12,989 $ 20,279 $ 2,220 $ 1,197,453 $ 13,178 Real estate - mortgage 2,453 77 1,256,453 12,563 3,758 147 1,167,365 11,328 Construction & land 1,792 122 213,380 3,324 1,919 109 172,532 1,888 Consumer 238 81 287,062 2,464 294 98 266,719 2,705 Other - - 108,505 981 - - 103,786 945 Unallocated - - - 887 - - - 675 Total $ 38,068 $ 3,642 $ 3,083,630 $ 33,208 $ 26,250 $ 2,574 $ 2,907,855 $ 30,719 Information on impaired loans at September 30, 2017 and December 31, 2016 is reported in the following tables: At September 30, 2017 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans allowance allowance allowance Commercial Manufacturing $ 3,342 $ 3,342 $ 3,342 $ - $ 192 Finance and insurance 475 475 475 - 50 Healthcare 528 528 437 91 201 Real estate services 5,123 5,123 5,123 - 287 Construction 1,864 1,864 1,710 154 278 Public administration 320 320 320 - 22 Other 22,273 21,933 20,709 1,224 2,332 33,925 33,585 32,116 1,469 3,362 Real estate - mortgage Residential & commercial owner-occupied 1,172 1,172 869 303 59 Residential & commercial investor 1,281 1,281 1,281 - 18 2,453 2,453 2,150 303 77 Construction & land 1,792 1,792 1,792 - 122 Consumer 238 238 81 157 81 Total $ 38,408 $ 38,068 $ 36,139 $ 1,929 $ 3,642 At December 31, 2016 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans allowance allowance allowance Commercial Manufacturing $ 2,095 $ 2,072 $ 2,071 $ 1 $ 114 Finance and insurance 25 25 25 - 25 Healthcare 189 189 189 - 11 Real estate services 6,268 6,268 6,268 - 350 Construction 2,166 2,166 1,932 234 149 Other 10,716 9,559 9,066 493 1,571 21,459 20,279 19,551 728 2,220 Real estate - mortgage Residential & commercial owner-occupied 1,391 1,391 1,122 269 64 Residential & commercial investor 2,367 2,367 2,367 - 83 3,758 3,758 3,489 269 147 Construction & land 1,919 1,919 1,919 - 109 Consumer 294 294 195 99 98 Total $ 27,430 $ 26,250 $ 25,154 $ 1,096 $ 2,574 Impaired loans Three months ended September 30, Nine months ended September 30, 2017 2016 2017 2016 (in thousands) Average recorded Interest income Average recorded Interest income Average recorded Interest income Average recorded Interest income Commercial Manufacturing $ 2,444 $ 30 $ 3,100 $ 31 $ 2,173 $ 89 $ 3,815 $ 122 Finance and insurance 476 6 28 - 349 16 31 - Healthcare 500 15 205 3 432 29 194 9 Real estate services 5,475 45 7,046 78 5,812 147 7,240 206 Construction 1,524 39 1,998 59 1,591 79 1,694 98 Public administration 106 1 - - 36 1 - - Other 19,998 467 11,598 150 16,421 869 12,861 407 30,523 603 23,975 321 26,814 1,230 25,835 842 Real estate - mortgage Residential & commercial owner-occupied 1,158 8 1,680 18 1,236 26 1,877 43 Residential & commercial investor 1,285 14 3,141 30 2,005 54 4,171 107 2,443 22 4,821 48 3,241 80 6,048 150 Construction & land 1,807 15 2,309 34 1,850 46 2,470 76 Consumer 242 5 243 4 244 7 504 18 Total $ 35,015 $ 645 $ 31,348 $ 407 $ 32,149 $ 1,363 $ 34,857 $ 1,086 Interest income recognized on impaired loans presented in the table above primarily represents interest earned on troubled debt restructurings that meet the definition of an impaired loan and are subject to disclosure required under ASU 310-10-50-15. The table below summarizes transactions related to troubled debt restructurings during the nine months ended September 30, 2017. (in thousands) Performing Nonperforming Total Beginning balance at December 31, 2016 $ 23,612 $ 2,541 $ 26,153 New restructurings 16,031 1,435 17,466 Change in accrual status (98) 98 - Net paydowns (6,340) (956) (7,296) Charge-offs - (41) (41) Ending balance at September 30, 2017 $ 33,205 $ 3,077 $ 36,282 The below table provides information regarding troubled debt restructurings that occurred during the three and nine months ended September 30, 2017 and 2016. Pre-modification outstanding recorded investment reflects the Company’s recorded investment immediately before the modification. Post-modification outstanding recorded investment represents the Company’s recorded investment at the end of the reporting period. The table below does not include loans restructured and paid-off during the periods presented. Three months ended September 30, 2017 Three months ended September 30, 2016 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing 1 $ 1,366 $ 1,366 - $ - $ - Construction - - - 2 1,500 1,444 Other 8 4,617 3,763 4 3,122 2,757 Total 9 $ 5,983 $ 5,129 6 $ 4,622 $ 4,201 Nine months ended September 30, 2017 Nine months ended September 30, 2016 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing 1 $ 1,366 $ 1,366 1 $ 50 $ 23 Finance and insurance 1 456 456 - - - Healthcare 3 465 304 1 100 100 Construction - - - 3 1,825 1,769 Public administration 1 320 320 - - - Other 13 14,472 13,230 8 6,640 5,726 19 17,079 15,676 13 8,615 7,618 Consumer 1 83 75 1 77 73 Total 20 $ 17,162 $ 15,751 14 $ 8,692 $ 7,691 Troubled debt restructurings during the three and nine months ended September 30, 2017 and 2016 resulted primarily from the extension of repayment terms and interest rate concessions. The Company had no charge-offs in conjunction with loans restructured during the three and nine months ended September 30, 2017 and 2016. At September 30, 2017 and December 31, 2016, there were $2.5 million and $1.6 million in outstanding commitments on restructured loans, respectively. There were no loans restructured within the past 12 months that had a payment default during the nine months ended September 30, 2017. The table below presents troubled loans restructured within the past 12 months that had a payment default during the nine months ended September 30, 2016. Nine months ended September 30, 2016 Troubled debt restructurings that subsequently defaulted Number of contracts Recorded investment Commercial Other 3 $ 1,586 The Company’s nonaccrual loans by class at September 30, 2017 and December 31, 2016 are reported in the following table: (in thousands) At September 30, 2017 At December 31, 2016 Commercial Manufacturing $ - $ 2 Finance and insurance 19 25 Healthcare 304 - Construction 1,006 234 Other 3,089 1,941 Total commercial 4,418 2,202 Real estate-mortgage Residential & commercial owner-occupied 303 269 Total real estate - mortgage 303 269 Consumer 142 167 Total nonaccrual loans $ 4,863 $ 2,638 The tables below summarize the aging of the Company’s loan portfolio at September 30, 2017 and December 31, 2016. At September 30, 2017 30 - 59 60 - 89 90 days or more Days Days 90+ Days Total past due and (in thousands) past due past due past due past due Current Total loans accruing Commercial Manufacturing $ 200 $ - $ - $ 200 $ 89,774 $ 89,974 $ - Finance and insurance 1,451 - - 1,451 38,505 39,956 - Healthcare 459 459 133 1,051 151,634 152,685 - Real estate services 250 - - 250 120,564 120,814 - Construction 438 - 375 813 66,594 67,407 - Public administration - - - - 249,870 249,870 - Other 1,096 3,122 1,024 5,242 524,309 529,551 20 3,894 3,581 1,532 9,007 1,241,250 1,250,257 20 Real estate - mortgage Residential & commercial owner-occupied 5 122 - 127 474,219 474,346 - Residential & commercial investor 892 233 - 1,125 784,177 785,302 - 897 355 - 1,252 1,258,396 1,259,648 - Construction & land - - - - 216,737 216,737 - Consumer 15 1,087 61 1,163 286,082 287,245 - Other - - - - 108,437 108,437 - Total loans held for investment $ 4,806 $ 5,023 $ 1,593 $ 11,422 $ 3,110,902 $ 3,122,324 $ 20 Unearned net loan fees (626) Net loans held for investment $ 3,121,698 At December 31, 2016 Recorded investment in loans 30 - 59 60 - 89 90 days or more Days Days 90+ Days Total past due and (in thousands) past due past due past due past due Current Total loans accruing Commercial Manufacturing $ - $ - $ - $ - $ 96,618 $ 96,618 $ - Finance and insurance 456 - 25 481 49,870 50,351 - Healthcare 500 - - 500 153,523 154,023 - Real estate services - - - - 126,044 126,044 - Construction 260 - - 260 58,458 58,718 - Public administration - - - - 255,997 255,997 - Other 2,941 200 - 3,141 472,109 475,250 - 4,157 200 25 4,382 1,212,619 1,217,001 - Real estate - mortgage Residential & commercial owner-occupied 204 161 - 365 475,158 475,523 - Residential & commercial investor - 225 - 225 695,848 696,073 - 204 386 - 590 1,171,006 1,171,596 - Construction & land - - 657 657 175,081 175,738 657 Consumer 4 63 75 142 266,805 266,947 - Other - - - - 103,616 103,616 - Total loans held for investment $ 4,365 $ 649 $ 757 $ 5,771 $ 2,929,127 $ 2,934,898 $ 657 Unearned net loan fees (793) Net loans held for investment $ 2,934,105

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	9 Months Ended
	Sep. 30, 2017
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income	6. Accumulated Other Comprehensive Income The following table provides information on reclassifications out of accumulated other comprehensive income. Three months ended Nine months ended September 30, September 30, AOCI component (in thousands) 2017 2016 2017 2016 Line item in Condensed Consolidated Statements of Income Available for sale securities: Realized gain (loss) $ (2) $ 98 $ (5) $ 95 Net (gain) loss on securities, other assets and OREO Taxes 1 (37) 2 (36) Provision for income taxes Subtotal (1) 61 (3) 59 Held to maturity securities: Amortization of net unrealized gain on HTM securities 469 459 1,313 1,385 Interest on taxable / nontaxable securities Taxes (178) (174) (497) (526) Provision for income taxes Subtotal 291 285 816 859 Cash flow hedges: Loans 129 151 595 463 Interest and fees on loans Debt (317) (426) (1,014) (1,296) Interest on subordinated debentures and notes payable Realized loss (188) (275) (419) (833) Taxes 71 105 158 317 Provision for income taxes Subtotal (117) (170) (261) (516) Total reclassifications out of AOCI $ 173 $ 176 $ 552 $ 402 The following table provides the beginning and ending balances of AOCI and changes during the nine months ended September 30, 2017. Accumulated other comprehensive income (in thousands) AFS HTM Cash flow hedges Total Balance at December 31, 2016 $ 1,658 $ 3,154 $ (4,246) $ 566 Other comprehensive income (loss) items 1,618 - 114 1,732 Reclassifications 3 (816) 261 (552) Other comprehensive income (loss), net of tax 1,621 (816) 375 1,180 Balance at September 30, 2017 $ 3,279 $ 2,338 $ (3,871) $ 1,746

Derivatives

Derivatives	9 Months Ended
	Sep. 30, 2017
Derivatives
Derivatives	7. Derivatives ASC 815 contains the authoritative guidance on accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and hedging activities. As required by ASC 815, the Company records all derivatives on the consolidated balance sheets at fair value. The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and unknown cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to certain variable-rate loan assets and variable-rate borrowings. The Company also enters into derivative financial instruments to protect against adverse changes in fair value on fixed-rate loans. The Company’s objective in using derivatives is to minimize the impact of interest rate fluctuations on the Company’s net interest income. To accomplish this objective, the Company uses interest rate swaps as part of its cash flow hedging strategy. The Company also offers an interest rate hedge program that includes various derivative products, including swaps, to assist its customers in managing their interest rate risk profile. In order to eliminate the interest rate risk associated with offering these products, the Company enters into derivative contracts with third parties to offset the customer contracts. These customer accommodation interest rate swap contracts are not designated as hedging instruments. The Company has also expanded its product offering by adding international banking products, which exposes the Company to foreign exchange risk. The Company utilizes foreign exchange forward contracts to manage the risk associated with fluctuation in foreign exchange rates. The Company has agreements with its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company could also be declared in default on its derivative obligations. Also, the Company has agreements with certain of its derivative counterparties that contain a provision where if the Bank fails to maintain its status as a well or adequately capitalized institution, then the counterparty could terminate the derivative positions and the Company would be required to settle its obligations under the agreements. At September 30, 2017, the fair value of derivatives in a net liability position, including accrued interest but excluding any adjustment for nonperformance risk, related to these agreements was $8.4 million. The Company has minimum collateral posting thresholds with certain of its derivative counterparties and has posted collateral of $8.6 million against its obligations under these agreements. At September 30, 2017, the Company was not in default under any of its debt or capitalization covenants. The table below presents the fair value of the Company’s derivative financial instruments as well as the classification within the Condensed Consolidated Balance Sheets. Asset derivatives Liability derivatives Fair value at Fair value at Balance sheet September 30, December 31, Balance sheet September 30, December 31, (in thousands) classification 2017 2016 classification 2017 2016 Derivatives designated as hedging instruments under ASC 815: Cash flow hedge - interest rate swap Other assets $ - $ - Accrued interest and other liabilities $ 6,584 $ 7,639 Fair value hedge - interest rate swap Other assets $ 400 $ 476 Accrued interest and other liabilities $ 920 $ 845 Derivatives not designated as hedging instruments under ASC 815: Interest rate swap Other assets $ 2,255 $ 2,755 Accrued interest and other liabilities $ 2,349 $ 2,736 Foreign exchange forward contracts Other assets $ 23 $ 52 Accrued interest and other liabilities $ 4 $ 5 The tables below include information about financial instruments that are eligible for offset. At September 30, 2017 Assets Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ 400 $ - $ 400 $ (400) $ - $ - Derivatives not designated as hedges (1) 2,278 - 2,278 (835) - 1,443 Total $ 2,678 $ - $ 2,678 $ (1,235) $ - $ 1,443 At September 30, 2017 Liabilities Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ (7,504) $ - $ (7,504) $ 400 $ 7,104 $ - Derivatives not designated as hedges (2) (2,353) - (2,353) 835 1,452 (66) Securities sold under agreements to repurchase (3) (60,335) - (60,335) - 60,335 - Total $ (70,192) $ - $ (70,192) $ 1,235 $ 68,891 $ (66) At December 31, 2016 Assets Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ 476 $ - $ 476 $ (476) $ - $ - Derivatives not designated as hedges (1) 2,807 - 2,807 (967) - 1,840 Total $ 3,283 $ - $ 3,283 $ (1,443) $ - $ 1,840 At December 31, 2016 Liabilities Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ (8,484) $ - $ (8,484) $ 476 $ 8,008 $ - Derivatives not designated as hedges (2) (2,741) - (2,741) 967 1,668 (106) Securities sold under agreements to repurchase (3) (27,639) - (27,639) - 27,639 - Total $ (38,864) $ - $ (38,864) $ 1,443 $ 37,315 $ (106) (1) Included in other assets. (2) Included in accrued interest and other liabilities. (3) Separately stated in the Condensed Consolidated Balance Sheets. Cash Flow Hedges of Interest Rate Risk — For hedges of the Company’s variable-rate loan assets, interest rate swaps designated as cash flow hedges involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount. During the first quarter of 2016, the Company terminated five interest rate swaps with a notional value of $75.0 million that had fixed the interest rate on a portion of its 1-month LIBOR loan portfolio. Upon termination, the Company had an unrealized gain of $1.3 million in AOCI. The unrealized gain will continue to be reported in AOCI, and will be reclassified to interest income over a period of three years. In October 2016, the Company entered into two interest rate swaps to hedge the risk of changes in cash flow on its LIBOR-based loan portfolio. The interest rate swaps have a weighted average term of approximately five years and have a combined notional value of $100.0 million. The Company will pay a variable rate based on 1-month LIBOR and receive a weighted average fixed-rate of 1.20%. For hedges of the Company’s variable-rate borrowings, interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments. The Company has executed a series of interest rate swap transactions in order to fix the effective interest rate for payments due on its junior subordinated debentures with the objective of reducing the Company’s exposure to adverse changes in cash flows relating to payments on its LIBOR-based floating rate debt. Select critical terms of the cash flow hedges are as follows: (in thousands) Notional Fixed rate Termination date Hedged item - Junior subordinated debentures issued by: CoBiz Statutory Trust I $ 20,000 % March 17, 2022 CoBiz Capital Trust II $ 30,000 % April 23, 2020 CoBiz Capital Trust III $ 20,000 % March 30, 2024 Based on the Company’s ongoing assessments (including at inception of the hedging relationship), it is probable that there will be sufficient variable interest payments through the maturity date of the swaps. The Company also monitors the risk of counterparty default on an ongoing basis. The Company uses a regression analysis and the “Hypothetical Derivative” method described in ASC 815, for both prospective and retrospective assessments of hedge effectiveness on a quarterly basis. The Company also uses the Hypothetical Derivative methodology to measure hedge ineffectiveness each period. The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in AOCI and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. The Company’s derivatives did not have any hedge ineffectiveness recognized in earnings during the three and nine months ended September 30, 2017 and 2016. Amounts reported in AOCI related to derivatives will be reclassified to interest income as interest payments are received/paid on the Company’s variable-rate assets. Payments received/paid on variable-rate liabilities will be reclassified to interest expense. During the next 12 months, the Company estimates that $1.1 million will be reclassified as an increase to interest expense and $0.1 million will be reclassified as an increase to interest income. Fair Value Hedges of Fixed-Rate Assets – The Company is exposed to changes in the fair value of certain of its fixed-rate assets due to changes in benchmark interest rates based on LIBOR. The Company uses interest rate swaps to manage its exposure to changes in fair value on certain fixed-rate loans. Interest rate swaps designated as fair value hedges involve the receipt of variable-rate payments from a counterparty in exchange for the Company’s fixed-rate payments over the life of the agreements without the exchange of the underlying notional amount. Certain interest rate swaps met the criteria to qualify for the shortcut method of accounting. Under the shortcut method of accounting, no ineffectiveness is assumed. For interest rate swaps not accounted for under the shortcut method, the Company performs ongoing retrospective and prospective effectiveness assessments (including at inception) using a regression analysis to compare periodic changes in fair value of the swaps to periodic changes in fair value of the fixed-rate loans attributable to changes in the benchmark interest rate. At September 30, 2017, the Company had interest rate swaps with a notional amount of $60.5 million used to hedge the change in the fair value of 11 commercial loans. For derivatives that are designated and qualify as fair value hedges that are not accounted for under the shortcut method, the gain or loss on the derivative as well as the gain or loss on the hedged item attributable to the hedged risk are recognized in earnings. The net amount recognized in “Other income” in the Condensed Consolidated Statements of Income during the three and nine months ended September 30, 2017 representing hedge ineffectiveness was immaterial. The net amount recognized in “Other income” in the Condensed Consolidated Statements of Income during the three and nine months ended September 30, 2016 representing hedge ineffectiveness was immaterial and $0.3 million, respectively. Non-designated Hedges — Derivatives not designated as hedges are not speculative and primarily result from a service the Company provides to its customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting interest rate swaps that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest rate swaps associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer swaps and the offsetting swaps are recognized directly in earnings. At September 30, 2017, the Company had 100 interest rate swaps with an aggregate notional amount of $259.3 million related to this program. During the three and nine months ended September 30, 2017 and 2016, gains and losses arising from changes in the fair value of these swaps, which are included in “Other income,” in the Condensed Consolidated Statements of Income, were immaterial. The Company’s product offerings also include international banking products that create foreign currency exchange-rate risk exposure. In order to economically reduce the risk associated with the fluctuation of foreign exchange rates, the Company utilizes short-term foreign exchange forward contracts to lock in exchange rates so the gain or loss on the forward contracts approximately offsets the transaction gain or loss. These contracts are not designated as hedging instruments. Ineffectiveness in the economic hedging relationship may occur as the foreign currency holdings are revalued based upon changes in the currency’s spot rate, while the forward contracts are revalued using the currency’s forward rates. Forward contracts in gain positions are recorded at fair value in “Other assets” and, forward contracts in loss positions are recorded in “Accrued interest and other liabilities” in the Condensed Consolidated Balance Sheets. Net changes in the fair value of the forward contracts are recognized through earnings, disclosed as ‘other’ noninterest income in the Condensed Consolidated Statements of Income. At September 30, 2017, the Company had forward contracts with a notional amount of $4.9 million that mature in less than one year. Net gains recognized and included in “Other income” in the Condensed Consolidated Statements of Income during the three and nine months ended September 30, 2017 totaled $0.2 million and $0.5 million, respectively. Net gains recognized during the three and nine months ended September 30, 2016 on foreign exchange forward contracts was $0.1 million and $0.3 million, respectively.

Borrowed Funds

Borrowed Funds	9 Months Ended
	Sep. 30, 2017
Borrowed Funds
Borrowed Funds	8. Borrowed Funds A summary of borrowed funds (excluding long-term debt) at September 30, 2017 and December 31, 2016 is included below. September 30, December 31, (in thousands) 2017 2016 Securities sold under agreements to repurchase (secured by pledge of mortgage-backed securities with an estimated fair value of $61,542 and $28,192, respectively) $ 60,335 $ 27,639 Other short-term borrowings 101,476 106,230 The Company enters into sales of securities under agreements to repurchase. The amounts received under these agreements represent short-term borrowings and are reflected as a liability in the Condensed Consolidated Balance Sheets. The securities underlying these agreements are included in investment securities in the Condensed Consolidated Balance Sheets. At September 30, 2017, all securities sold under agreements to repurchase had a maturity date of less than three months. The Company has no control over the market value of the securities, which fluctuates due to market conditions. However, the Company is obligated to promptly transfer additional securities if the market value of the securities falls below the repurchase agreement price. The Company manages this risk by maintaining an unpledged securities portfolio that it believes is sufficient to cover a decline in the market value of the securities sold under agreements to repurchase. Securities sold under agreements to repurchase averaged $59.8 million in the first nine months of 2017 and $46.0 million in the year ended December 31, 2016. The maximum amounts outstanding at any month-end during the first nine months of 2017 was $69.9 million. The maximum amounts outstanding at any month-end during 2016 was $71.0 million. At September 30, 2017 and December 31, 2016, the weighted average interest rate was 0.06% and 0.07%, respectively. The Company has a line of credit with the FHLB with a rolling one-year term that matures every July with automatic renewals unless canceled. The average FHLB line of credit balance was $133.0 million in the first nine months of 2017 and $82.8 million in the year ended December 31, 2016. The line of credit is collateralized by either qualifying loans or investment securities not otherwise pledged as collateral. The Company pledged loans of $851.7 million and $861.0 million with a lending value of $588.9 million and $598.5 million at September 30, 2017 and December 31, 2016, respectively, as collateral for the FHLB line of credit. The variable rate on the line of credit was 1.28% and 0.72% at September 30, 2017 and December 31, 2016, respectively. The Company has also pledged $817.1 million of loans at September 30, 2017 to the Federal Reserve Bank of Kansas City as collateral for borrowing through the discount window lending program. At September 30, 2017 and December 31, 2016, there was no amount outstanding with the discount window. The Company has a revolving Line of Credit (LOC) agreement with an aggregate principal sum of up to $20.0 million bearing interest at 1-month LIBOR plus 225 basis points (2.25%). The Company pays a quarterly commitment fee of 0.35% per annum on the unused portion of the LOC. The LOC matures May 2018, at which time any outstanding amounts are due and payable. Proceeds from the LOC will be used for general corporate purposes and backup liquidity. Although the LOC is unsecured, the Company has agreed not to sell, pledge or transfer any part of its right, title or interest in the Bank. At September 30, 2017 and December 31, 2016, there was no amount outstanding on the LOC. The Company has approved federal fund purchase lines with eight banks with an aggregate credit line of $180.0 million. At September 30, 2017 $1.5 million was outstanding on the federal funds purchase lines, and no amount was outstanding at December 31, 2016. The average balance of federal funds purchased was $1.6 million in the first nine months of 2017 and $2.0 million during the year-ended December 31, 2016.

Employee Benefit and Stock Comp

Employee Benefit and Stock Compensation Plans	9 Months Ended
	Sep. 30, 2017
Employee Benefit and Stock Compensation Plans
Employee Benefit And Stock Compensation Plans	9. Employee Benefit and Stock Compensation Plans Stock Options and Awards During the three and nine months ended September 30, 2017, the Company recognized stock-based compensation expense of $0.7 million and $2.6 million, respectively. The following table summarizes changes in option awards during the nine months ended September 30, 2017. Weighted average Shares exercise price Outstanding at December 31, 2016 285,999 $ 10.45 Granted 34,500 16.94 Exercised (96,703) 9.80 Forfeited (15,200) 11.99 Outstanding at September 30, 2017 208,596 $ 11.71 Exercisable at September 30, 2017 112,952 $ 10.10 The weighted average grant date fair value of options granted during the nine months ended September 30, 2017 was $3.42. The following table summarizes changes in stock awards during the nine months ended September 30, 2017. Weighted average Shares grant date fair value Unvested at December 31, 2016 467,203 $ 11.50 Granted 199,146 16.99 Vested (253,407) 11.93 Forfeited (8,036) 12.81 Unvested at September 30, 2017 404,906 $ 13.90 At September 30, 2017, there was $4.3 million of total unrecognized compensation expenses related to unvested share-based compensation arrangements granted under the plans. The expense is expected to be recognized over a weighted-average period of 1.9 years.

Segments

Segments	9 Months Ended
	Sep. 30, 2017
Segments
Segments	10. Segments The Company’s operating segments consist of Commercial Banking, Fee-Based Lines and Corporate Support and Other. The financial information for the Commercial Banking and Fee-Based Lines segments reflect activities which are specifically identifiable or which are allocated based on an internal allocation method. The Corporate Support and Other segment includes activities that are not directly attributable to the other reportable segments including centralized bank operations and the activities of the Parent. The following tables report the results of operations for the three and nine months ended September 30, 2017 and 2016 by segment. Three months ended September 30, 2017 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ 36,862 $ - $ 85 $ 36,947 Total interest expense 1,327 (1) 1,852 3,178 Provision for loan losses 1,098 - (38) 1,060 Noninterest income 3,777 4,888 330 8,995 Noninterest expense 8,658 4,237 13,497 26,392 Management fees and allocations, net of tax 7,881 290 (8,171) - Provision (benefit) for income taxes 9,661 239 (5,781) 4,119 Net income (loss) $ 12,014 $ 123 $ (944) $ 11,193 Nine months ended September 30, 2017 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ 105,176 $ 1 $ 257 $ 105,434 Total interest expense 4,085 13 5,484 9,582 Provision for loan losses 2,472 - (132) 2,340 Noninterest income 10,447 14,468 719 25,634 Noninterest expense 26,222 13,003 40,936 80,161 Management fees and allocations, net of tax 23,930 882 (24,812) - Provision (benefit) for income taxes 26,423 511 (17,245) 9,689 Net income (loss) $ 32,491 $ 60 $ (3,255) $ 29,296 Three months ended September 30, 2016 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ 32,216 $ - $ 92 $ 32,308 Total interest expense 1,078 11 1,818 2,907 Provision for loan losses (1,158) - (10) (1,168) Noninterest income 3,622 4,536 1,128 9,286 Noninterest expense 9,731 4,055 12,257 26,043 Management fees and allocations, net of tax 7,757 464 (8,221) - Provision (benefit) for income taxes 7,535 165 (4,157) 3,543 Net income (loss) $ 10,895 $ (159) $ (467) $ 10,269 Nine months ended September 30, 2016 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ 94,727 $ 1 $ 275 $ 95,003 Total interest expense 3,369 25 5,446 8,840 Provision for loan losses (2,300) - (150) (2,450) Noninterest income 9,318 13,578 1,890 24,786 Noninterest expense 27,715 12,807 37,621 78,143 Management fees and allocations, net of tax 23,831 1,255 (25,086) - Provision (benefit) for income taxes 21,888 277 (13,075) 9,090 Net income (loss) $ 29,542 $ (785) $ (2,591) $ 26,166

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2017
Fair Value Measurements
Fair Value Measurements	11. Fair Value Measurements ASC 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing an asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). · Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. · Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates and yield curves that are observable at commonly quoted intervals. · Level 3 inputs are unobservable inputs for the asset or liability, which is typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability. The Company evaluates fair value measurement inputs on an ongoing basis in order to determine if there is a change of sufficient significance to warrant a transfer between levels. For example, changes in market activity or the addition of new unobservable inputs could, in the Company’s judgment, cause a transfer to either a higher or lower level. Assets and liabilities measured on a recurring basis A description of the valuation methodologies used for financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below. Available for sale securities – At September 30, 2017, the Company held, as part of its investment portfolio, available for sale securities reported at fair value consisting of municipal securities, corporate debt securities, and TPS. The fair value of the majority of municipal securities is determined using widely accepted valuation techniques including matrix pricing and broker-quote based applications. Inputs include benchmark yields, reported trades, issuer spreads, and other relevant items. As a result, the Company has determined that these valuations fall within Level 2 of the fair value hierarchy. The Company also holds TPS that are recorded at fair value based on unadjusted quoted market prices for identical securities in an active market. The majority of the TPS are actively traded in the market and as a result, the Company has determined that the valuation of these securities falls within Level 1 of the fair value hierarchy. The Company also holds certain TPS and corporate debt securities for which unadjusted market prices are not available or the markets are not active and are therefore classified as Level 2 or Level 3. The Company uses broker-dealer quotes, valuations based on similar but not identical securities, or the most recent market trade (which may not be current) to price these securities. Total net unrealized gain recognized in AOCI at September 30, 2017 on TPS Level 3 securities was immaterial. Derivative financial instruments – The Company uses interest rate swaps as part of its cash flow strategy to manage its interest rate risk. The valuation of these instruments is determined using widely accepted valuation techniques as discussed further below. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. Pursuant to guidance in ASC 820, credit valuation adjustments are incorporated into the valuation to appropriately reflect both the Company’s own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings and thresholds. The Company uses Level 2 and Level 3 inputs to determine the valuation of its derivatives portfolio. The valuation of derivative instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs (Level 2 inputs), including interest rate curves and implied volatilities. The estimates of fair value are made using a standardized methodology that nets the discounted expected future cash receipts and cash payments (based on observable market inputs). Level 3 inputs include the credit valuation adjustments which use estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. At September 30, 2017 and December 31, 2016, the Company assessed the impact of the Level 3 inputs on the overall derivative valuations in terms of the significance of the credit valuation adjustments in basis points and as a percentage of the overall derivative portfolio valuation and the overall notional value. The Company’s assessment determined that credit valuation adjustments were not significant to the overall valuation of the portfolio. In addition, the significance of the credit value adjustments and overall derivative portfolio to the Company’s financial statements was considered. As a result of the insignificance of the credit value adjustments to the derivative portfolio valuations and the Company’s financial statements, the Company classified the derivative valuations in their entirety in Level 2. The Company uses foreign exchange forward contracts to mitigate exchange-rate risk arising from the Company’s foreign currency holdings to support its international banking product offering. Fair value measurements of these assets or liabilities are priced based on spot and forward foreign currency rates and the credit worthiness of the contract counterparty. These contracts are classified in Level 2. The following tables present the Company’s assets and liabilities measured at fair value on a recurring basis at September 30, 2017 and December 31, 2016, aggregated by the level in the fair value hierarchy within which those measurements fall. Fair value measurements using: Quoted prices in Significant Significant active markets for observable unobservable Balance at identical assets inputs inputs (in thousands) September 30, 2017 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ 38,691 $ 4,433 $ 25,091 $ 9,167 Corporate debt securities 135,590 - 135,590 - Municipal securities 3,310 - 3,310 - Total available for sale securities $ 177,591 $ 4,433 $ 163,991 $ 9,167 Derivatives: Fair value hedges $ 400 $ - $ 400 $ - Non-designated hedges 2,255 - 2,255 - Foreign exchange forward contracts 23 - 23 - Total derivative assets $ 2,678 $ - $ 2,678 $ - Liabilities Derivatives: Cash flow hedges $ 6,584 $ - $ 6,584 $ - Fair value hedges 920 - 920 - Non-designated hedges 2,349 - 2,349 - Foreign exchange forward contracts 4 - 4 - Total derivative liabilities $ 9,857 $ - $ 9,857 $ - Fair value measurements using: Quoted prices in Significant Significant active markets for observable unobservable Balance at identical assets inputs inputs (in thousands) December 31, 2016 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ 37,624 $ 4,283 $ 23,893 $ 9,448 Corporate debt securities 92,077 - 92,077 - Municipal securities 3,280 - 3,280 - Total available for sale securities $ 132,981 $ 4,283 $ 119,250 $ 9,448 Derivatives: Fair value hedges $ 476 $ - $ 476 $ - Non-designated hedges 2,755 - 2,755 - Foreign exchange forward contracts 52 - 52 - Total derivative assets $ 3,283 $ - $ 3,283 $ - Liabilities Derivatives: Cash flow hedges $ 7,639 $ - $ 7,639 $ - Fair value hedge 845 - 845 - Non-designated hedges 2,736 - 2,736 - Foreign exchange forward contracts 5 - 5 - Total derivative liabilities $ 11,225 $ - $ 11,225 $ - A reconciliation of the beginning and ending balances of assets measured at fair value, on a recurring basis, using Level 3 inputs follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2017 2016 2017 2016 Beginning balance $ 10,198 $ 8,955 $ 9,448 $ 5,810 Transfers and purchases - - - 3,276 Net accretion 28 29 87 60 Sales / calls / maturities (1,000) - (1,000) - Unrealized gain (loss) included in comprehensive income (59) 291 632 129 Ending balance $ 9,167 $ 9,275 $ 9,167 $ 9,275 Assets and liabilities measured on a nonrecurring basis Fair value is used on a nonrecurring basis to evaluate certain financial assets and financial liabilities in specific circumstances. Similarly, fair value is used on a nonrecurring basis for nonfinancial assets and nonfinancial liabilities such as foreclosed assets, other real estate owned, intangible assets, nonfinancial assets and liabilities evaluated in a goodwill impairment analysis and other nonfinancial assets measured at fair value for purposes of assessing impairment. A description of the valuation methodologies used for financial and nonfinancial assets and liabilities measured at fair value, as well as the general classification of such assets and liabilities pursuant to the valuation hierarchy, is set forth below. Impaired loans – Certain collateral-dependent impaired loans are reported at the fair value of the underlying collateral. Impairment is measured based on the fair value of the collateral, which is typically derived from appraisals that take into consideration prices in observed transactions involving similar assets and similar locations. Each appraisal is updated on an annual basis, either through a new appraisal, a new evaluation or through the Company’s comprehensive internal review process. Appraised values are reviewed and monitored internally and fair value is assessed at least quarterly or more frequently when circumstances occur that indicate a change in fair value has occurred. The Company classified impaired loans as Level 3. Other real estate owned (OREO) – OREO represents real property taken by the Company either through foreclosure or through a deed in lieu thereof from the borrower. The fair value of OREO is based on property appraisals adjusted at management’s discretion to reflect a further decline in the fair value of properties since the time the appraisal analysis was performed. Therefore, the inputs used to determine the fair value of OREO fall within Level 3. The Company may include within OREO other repossessed assets received as partial satisfaction of a loan. Other repossessed assets are not material and do not typically have readily determinable market values and are considered Level 3 inputs. The following table presents the Company’s assets measured at fair value on a nonrecurring basis at the dates specified in the following table, aggregated by the level in the fair value hierarchy within which those measurements fall. Fair value measurements using: Quoted prices in Significant Significant active markets for observable unobservable identical assets inputs inputs (in thousands) Total (Level 1) (Level 2) (Level 3) At September 30, 2017 Impaired loans $ 2,969 $ - $ - $ 2,969 OREO $ 5,351 $ - $ - $ 5,351 At December 31, 2016 Impaired loans $ 1,425 $ - $ - $ 1,425 OREO $ 5,351 $ - $ - $ 5,351 Gains and losses, which include the provision for losses on impaired loans, recorded in relation to assets and liabilities measured on a nonrecurring basis are presented below: Gain for the three months ended Gain for the nine months ended September 30, September 30, (in thousands) 2017 2016 2017 2016 Impaired loans $ 38 $ 975 $ 1,009 $ 3,149 In accordance with ASC 310, the fair value of OREO recorded as an asset is reduced by estimated selling costs. The following table is a reconciliation of the fair value measurement of OREO disclosed pursuant to ASC 820 to the amount recorded on the Condensed Consolidated Balance Sheets: At At (in thousands) September 30, 2017 December 31, 2016 OREO recorded at fair value $ 5,351 $ 5,351 Estimated selling costs (272) (272) OREO $ 5,079 $ 5,079 The following tables provide information describing the valuation techniques used to determine recurring and nonrecurring fair value measurements categorized within Level 3 of the fair value hierarchy at September 30, 2017 and December 31, 2016. At September 30, 2017 Fair value Weighted Category (in thousands) Valuation technique Unobservable input average Range Trust preferred securities $ 9,167 Market approach Discount to carrying value using broker quotes or observable prices on similar securities 7 % 5% to 13% Impaired loans: Commercial $ 2,509 Sales comparison (1) Management discount for asset type 53 % 0% - 90% Real estate - mortgage 303 Sales comparison (2) Sales comparison adjustments (2) % (1)% - (4)% Consumer 157 Sales comparison (2) Sales comparison adjustments (36) % (13)% - (59)% Total impaired loans $ 2,969 OREO: Commercial $ 190 Property appraisals (2) Management discount for property type 0 % NA Construction & land 5,161 Property appraisals (2) Management discount for property type 17 % NA Total OREO $ 5,351 At December 31, 2016 Fair value Weighted Category (in thousands) Valuation technique Unobservable input average Range Trust preferred securities $ 9,448 Market approach Discount to carrying value using broker quotes or observable prices on similar securities 13 % 1% to 28% Impaired loans: Commercial $ 1,057 Sales comparison (1) Management discount for asset type 59 % 0% to 76% Real estate - mortgage 269 Sales comparison (2) Sales comparison adjustments 18 % NA Consumer 99 Sales comparison (2) Sales comparison adjustments (1) % (11)% to 10% Total impaired loans $ 1,425 OREO: Commercial $ 190 Property appraisals (2) Management discount for property type 0 % 0% Construction & land 5,161 Property appraisals (2) Management discount for property type 17 % NA Total OREO $ 5,351 (1) Discount represents management’s discounts applied to market valuation of various business asset types including accounts receivable and other commercial assets. (2) The fair value of OREO and collateral-dependent impaired loans is based on third-party property appraisals. The majority of the appraisals utilize at least two valuation approaches or a combination of approaches including a market approach, where prices and other relevant information generated by market transactions involving similar or comparable properties are used to determine fair value. Appraisals may include an ‘as is’ and ‘upon completion’ valuation approach. Adjustments are routinely made in the appraisal process by third-party appraisers to adjust for differences between the comparable sales and income data. Adjustments also result from the consideration of relevant economic and demographic factors with the potential to affect property values. Also, prospective values are based on the market conditions which exist at the date of inspection combined with informed forecasts based on current trends in supply and demand for the property types under appraisal. Positive adjustments disclosed in these tables represent increases and negative adjustments represent decreases in fair value. The following table includes the estimated fair value of the Company’s financial instruments. The methodologies for estimating the fair value of financial assets and financial liabilities measured at fair value on a recurring and nonrecurring basis are discussed above. The methodologies for estimating the fair value for other financial assets and financial liabilities are discussed below. The estimated fair value amounts have been determined by the Company using available market information and appropriate valuation methodologies. However, considerable judgment is required to interpret market data in order to develop the estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts at September 30, 2017 and December 31, 2016. September 30, 2017 December 31, 2016 Carrying Estimated Carrying Estimated (in thousands) value fair value value fair value Financial assets: Cash and cash equivalents $ 79,305 $ 79,305 $ 96,050 $ 96,050 Investment securities available for sale 177,591 177,591 132,981 132,981 Investment securities held to maturity 360,935 360,380 366,041 363,178 Other investments 2,174 2,174 2,173 2,173 Loans — net 3,084,848 3,080,579 2,900,812 2,868,091 Accrued interest receivable 13,698 13,698 12,223 12,223 Derivatives 2,678 2,678 3,283 3,283 Financial liabilities: Deposits $ 3,177,532 $ 3,176,777 $ 3,029,783 $ 3,029,226 Securities sold under agreements to repurchase 60,335 56,667 27,639 26,101 Other short-term borrowings 101,476 101,476 106,230 106,230 Accrued interest payable 1,876 1,876 1,038 1,038 Subordinated notes payable 59,173 58,983 59,111 58,681 Junior subordinated debentures 72,166 72,166 72,166 72,166 Derivatives 9,857 9,857 11,225 11,225 The fair value estimation methodologies utilized by the Company for financial instruments and the classification level within the fair value hierarchy that those instruments fall are summarized as follows: Cash and cash equivalents — The carrying amount of cash and cash equivalents is a reasonable estimate of fair value which is classified as Level 2. Other investments — Included in this category are the Company’s investments in other equity method investments. Due to restrictions on transferability, it is not practical to estimate fair value on the Bank stocks which are excluded from the table above. The fair value of other equity method investments approximates fair value and is classified as Level 2. Loans — The fair value of loans is estimated by discounting future contractual cash flows using estimated market rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. In computing the estimate of fair value for all loans, the estimated cash flows and/or carrying value have been reduced by specific and general reserves for loan losses. The fair value of loans disclosed in the table above, which is not the exit price, is classified as Level 3 within the fair value hierarchy. Accrued interest receivable/payable — The fair value of accrued interest receivable/payable approximates the carrying amount due to the short-term nature of these amounts and is classified in the same level hierarchy as the underlying assets/liabilities. Deposits — The fair value of certificates of deposit is estimated by discounting the expected life using an index of the U.S. Treasury curve. Non-maturity deposits are reflected at their carrying value for purposes of estimating fair value. The fair value of all deposits is classified as Level 2. Securities sold under agreements to repurchase — Estimated fair value is based on discounting cash flows and is classified as Level 2. Short-term borrowings — The estimated fair value of short-term borrowings approximates their carrying value, due to their short-term nature and is classified as Level 2. Subordinated notes payable — The estimated fair value of subordinated notes payable is based on discounting cash flows for comparable instruments and is classified as Level 3. Junior subordinated debentures — The estimated fair value of junior subordinated debentures approximates their carrying value, due to the variable interest rate paid on the debentures and is classified as Level 2. Commitments to extend credit and standby letters of credit — The Company’s off-balance sheet commitments are funded at current market rates at the date they are drawn upon. It is management’s opinion that the fair value of these commitments would approximate their carrying value, if drawn upon, and are classified as Level 3. The fair value estimates presented herein are based on pertinent information available to management at September 30, 2017 and December 31, 2016. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these financial statements since that date and, therefore, current estimates of fair value may differ significantly from the amounts presented herein.

Regulatory Matters

Regulatory Matters	9 Months Ended
	Sep. 30, 2017
Regulatory Matters
Regulatory Matters	12. Regulatory Matters The following table presents the regulatory capital ratios of the Bank and Holding Company, including regulatory thresholds, at September 30, 2017. The minimum Capital Conservation Buffer (CCB) for 2017 increased to 1.25% from 0.625% in 2016, the first year the requirement was effective. The CCB increases 0.625% annually through 2019 to 2.5% and is designed to establish a capital range for banking organizations above minimum requirements to insulate banks from periods of stress and impose constraints on dividends, share repurchases and discretionary bonus payments when capital levels fall below prescribed levels. At September 30, 2017 Capitalized Ratio Bank Company Minimum ratio (in thousands) Ratios Ratios Well (1) plus fully phased-in CCB Common equity tier 1 capital 12.0 % 10.0 % 6.5 % % Tier 1 capital 12.0 % 11.6 % 8.0 % % Total capital 13.1 % 14.5 % 10.0 % % Tier 1 leverage 10.4 % 10.0 % 5.0 % % (1) The ratios for the well-capitalized requirement are only applicable to the Bank. However, the Company manages its capital position as if the requirement applies to the consolidated entity and has presented the ratios as if they also applied to the Company.

Supplemental Financial Data

Supplemental Financial Data	9 Months Ended
	Sep. 30, 2017
Supplemental Financial Data
Supplemental Financial Data	13. Supplemental Financial Data Other noninterest income and other noninterest expense as shown in the Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2017 and 2016 are detailed in the following tables. Three months ended Nine months ended Other noninterest income September 30, September 30, (in thousands) 2017 2016 2017 2016 Loan fees $ 953 $ 795 $ 1,816 $ 1,737 Other customer service fees 741 694 2,163 2,023 Bank-owned life insurance 356 345 1,015 1,000 Other investments 355 1,348 1,102 2,262 Derivative valuation (35) - (172) (456) Other 77 15 123 134 Total $ 2,447 $ 3,197 $ 6,047 $ 6,700 Three months ended Nine months ended Other noninterest expense September 30, September 30, (in thousands) 2017 2016 2017 2016 Marketing and business development $ 603 $ 559 $ 1,991 $ 2,104 Service contracts 1,374 1,331 4,095 3,855 Professional fees 923 824 2,621 2,135 Office supplies and delivery 313 336 894 972 Other 540 947 2,408 2,861 Total $ 3,753 $ 3,997 $ 12,009 $ 11,927

Nature of Operations and Sign20

Nature of Operations and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2017
Nature of Operations and Significant Accounting Policies
Basis of Presentation	Basis of Presentation — The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Form 10-Q and, where applicable, prevailing practices within the financial services industry. The December 31, 2016 Condensed Consolidated balance sheet has been derived from the audited financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2016. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting only of normally recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2017, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017. In preparing its financial statements, the Company is required to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. These Condensed Consolidated Financial Statements and notes thereto should be read in conjunction with, and are qualified in their entirety by, the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, as filed with the U.S. Securities and Exchange Commission (SEC). The Condensed Consolidated Financial Statements include entities in which the Parent has a controlling financial interest. These entities include: the Bank; CoBiz Insurance, Inc.; and CoBiz IM. Intercompany balances and transactions are eliminated in consolidation. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity (VIE). The voting interest model is used when the equity investment is sufficient to absorb the expected losses and the equity investment has all of the characteristics of a controlling financial interest. Under the voting interest model, the party with the controlling voting interest consolidates the legal entity. The VIE model is used when any of the following conditions exist: the equity investment at risk is not sufficient to finance the entity’s activities without additional subordinated financial support; the holders of the equity investment do not have a controlling voting interest; or the holders of the equity investment are not obligated to absorb the expected losses or residual returns of the legal entity. An enterprise is considered to have a controlling financial interest of a VIE if it has both the power to direct the activities that most significantly impact economic performance and the obligation to absorb losses, or receive benefits, that are significant to the VIE. An enterprise that has a controlling financial interest is considered the primary beneficiary and must consolidate the VIE. The Company was not the primary beneficiary of a VIE at September 30, 2017 or December 31, 2016. Certain reclassifications have been made to prior years’ Condensed Consolidated Financial Statements and related notes to conform to the current year presentation.
Cash and Cash Equivalents	Cash and Cash Equivalents — The Company considers all liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include amounts that the Company is required to maintain at the Federal Reserve Bank of Kansas City to meet certain regulatory reserve balance requirements. The following table shows supplemental disclosures of certain cash and noncash items: Nine months ended September 30, (in thousands) 2017 2016 Cash paid during the period for: Interest $ 8,745 $ 8,141 Income taxes 8,112 5,538 Other noncash activities: Loans transferred to held for sale $ - $ 60 Lessor-paid tenant improvement allowance 358 -
Investments	Investments — The Company classifies its investment securities as held to maturity, available for sale or trading, according to management’s intent. Investment security transactions are recorded on a trade date basis. At September 30, 2017 and December 31, 2016, the Company had no trading securities. Available for sale securities consist of bonds, notes and debentures (including corporate debt and trust preferred securities (TPS)) not classified as held to maturity securities and are reported at fair value as determined by quoted market prices. Unrealized holding gains and losses, net of tax, are reported as a net amount in AOCI until realized. Investment securities held to maturity consist of residential mortgage-backed securities (MBS), bonds, notes and debentures for which the Company has the positive intent and ability to hold to maturity and are reported at cost, adjusted for amortization or accretion of premiums and discounts. Premiums and discounts, adjusted for prepayments as applicable, are recognized in interest income. Other than temporary declines in the fair value of individual investment securities held to maturity and available for sale are charged against earnings. Gains and losses on disposal of investment securities are determined using the specific-identification method. Other-than-temporary-impairment (OTTI) on debt securities is separated between the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income (OCI).
Bank Stocks	Bank Stocks — Federal Home Loan Bank of Topeka (FHLB), Federal Reserve Bank and other correspondent bank stocks are accounted for under the cost method.
Loans Held for Investment	Loans Held for Investment — Loans that the Company has the intent and ability to hold for the foreseeable future or until maturity or pay-off are reported at their outstanding principal balance adjusted for any charge-offs, the allowance for loan losses, deferred fees and costs on originated loans, and unamortized premiums or discounts on purchased loans. Interest is accrued and credited to income daily based on the principal balance outstanding. Loans that are 30 days or more past due based on payments received and applied to the loan are considered delinquent, excluding loans that are cash-secured. The accrual of interest income is generally discontinued when a loan becomes 90 days past due as to principal and interest. When a loan is designated as nonaccrual, the current period’s accrued interest receivable is charged against current earnings while any portions relating to prior periods are charged against the allowance for loan losses. Interest payments received on nonaccrual loans are generally applied to the principal balance of the loan. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured and there has been demonstrated performance in accordance with contractual terms. The Company may elect to continue the accrual of interest when the loan is in the process of collection and the realizable value of collateral is sufficient to cover the principal balance and accrued interest.
Loans Held for Sale	Loans Held for Sale — Loans held for sale include loans the Company has demonstrated its ability and intent to sell. Loans held for sale are primarily nonperforming loans. Loans held for sale are carried at the lower of cost or fair value and are evaluated on a loan-by-loan basis.
Impaired Loans	Impaired Loans — Impaired loans, with the exception of groups of smaller-balance homogenous loans that are collectively evaluated for impairment, are defined as loans for which, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays of less than 90 days and monthly payment shortfalls of less than 10% of the contractual payment on a consumer loan generally are not classified as impaired if the Company ultimately expects to recover its full investment. The Company determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Loans that are deemed to be impaired are evaluated in accordance with Accounting Standards Codification (ASC) Topic 310-10-35, Receivables – Subsequent Measurement (ASC 310) and ASC Topic 450-20, Loss Contingencies (ASC 450). Included in impaired loans are troubled debt restructurings. A troubled debt restructuring is a formal restructure of a loan where the Company, for economic or legal reasons related to the borrower’s financial difficulties, grants a concession to the borrower. The concessions may be granted in various forms, including but not limited to reduction in the stated interest rate, reduction in the loan balance or accrued interest, or extension of the maturity date. Troubled debt restructurings are evaluated in accordance with ASC Topic 310-40, Troubled Debt Restructurings by Creditors. Interest payments on impaired loans are typically applied to principal unless collectability of principal is reasonably assured. Loans that have been modified in a formal restructuring are typically returned to accrual status when there has been a sustained period of performance (generally six months) under the modified terms, the borrower has shown the ability and willingness to repay and the Company expects to collect all amounts due under the modified terms.
Loan Origination Fees and Costs	Loan Origination Fees and Costs — Loan fees and certain costs of originating loans are deferred and the net amount is amortized over the contractual life of the related loans in accordance with ASC Topic 310-20, Nonrefundable Fees and Other Costs.
Allowance for Loan Losses	Allowance for Loan Losses — The allowance for loan losses (ALL) is established as losses are estimated to have occurred through a provision for loan losses charged against earnings. Loan losses are charged against the ALL when management believes the uncollectability of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the ALL. The ALL is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral, and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as new information becomes available.
Allowance for Credit Losses	Allowance for Credit Losses — The allowance for credit losses is established as losses are estimated to have occurred through a provision for credit losses charged to earnings. The allowance for credit losses represents management’s recognition of a separate reserve for off-balance sheet loan commitments and letters of credit. While the allowance for loan losses is recorded as a contra-asset to the loan portfolio on the Condensed Consolidated Balance Sheets, the allowance for credit losses is recorded under the caption “Accrued interest and other liabilities”. Although the allowances are presented separately on the balance sheets, any losses incurred from credit losses would be reported as a charge-off in the allowance for loan losses, as any loss would be recorded after the off-balance sheet commitment had been funded.
Bank-Owned Life Insurance (BOLI)	Bank-Owned Life Insurance (BOLI) – The Bank has invested in BOLI policies to fund certain future employee benefit costs. The policies are recorded at net realizable value. Changes in the amount that could be realized, including death benefits in excess of the carrying amount, are recorded in the Condensed Consolidated Statements of Income as “Other income”.
Derivative Instruments	Derivative Instruments — Derivative financial instruments are accounted for at fair value. The Company utilizes interest rate swaps to hedge a portion of its exposure to interest rate changes. These instruments are accounted for as cash flow hedges, as defined by ASC Topic 815, Derivatives and Hedging (ASC 815). The Company also uses interest rate swaps to hedge against adverse changes in fair value on fixed-rate loans. These instruments are accounted for as fair value hedges in accordance with ASC 815. The net cash flows from the cash flow and fair value hedges are classified in operating activities within the Condensed Consolidated Statements of Cash Flows with the hedged items. The Company also offers an interest-rate hedge program that includes various derivative products, including swaps, to customers of the Bank. The fair value amounts recognized for derivative instruments and the fair value amounts recognized for the right to reclaim or obligation to return cash collateral are not offset when represented under a master netting arrangement. The Company also uses foreign currency forward contracts (FX forwards) giving it the right to sell underlying currencies at specified future dates and predetermined prices in order to mitigate foreign exchange risk associated with long positions. FX forwards are carried at fair value with changes in value recognized in current earnings as the contracts are not designated as hedging instruments.
Fair Value Measurements	Fair Value Measurements — The Company measures financial assets, financial liabilities, nonfinancial assets and nonfinancial liabilities pursuant to ASC Topic 820, Fair Value Measurement and Disclosures (ASC 820). ASC 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
Warrant	Warrant — The Company issued a warrant on December 19, 2008 as part of the Company’s participation in the federal Troubled Asset Relief Plan (TARP) Capital Purchase Program under the Emergency Economic Stabilization Act of 2008. The warrant had a 10-year term and allowed for the purchase of 895,968 shares of the Company’s common stock at an exercise price of $10.79 per share. On October 20, 2017 the warrant was exercised in a cashless transaction and the Company issued 432,299 shares of common stock in full settlement of the warrant.

Nature of Operations and Sign21

Nature of Operations and Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2017
Nature of Operations and Significant Accounting Policies
Schedule of Cash Flow, Supplemental Disclosures	Nine months ended September 30, (in thousands) 2017 2016 Cash paid during the period for: Interest $ 8,745 $ 8,141 Income taxes 8,112 5,538 Other noncash activities: Loans transferred to held for sale $ - $ 60 Lessor-paid tenant improvement allowance 358 -

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2017
Investments
Summary of amortized cost and estimated fair values of investment securities	At September 30, 2017 At December 31, 2016 Gross Gross Gross Gross Amortized unrealized unrealized Fair Amortized unrealized unrealized Fair (in thousands) cost gains losses value cost gains losses value Available for sale securities (AFS): Trust preferred securities $ 35,607 $ 3,464 $ 380 $ 38,691 $ 36,450 $ 1,707 $ 533 $ 37,624 Corporate debt securities 133,460 2,142 12 135,590 90,593 1,505 21 92,077 Municipal securities 3,254 60 4 3,310 3,265 33 18 3,280 Total AFS $ 172,321 $ 5,666 $ 396 $ 177,591 $ 130,308 $ 3,245 $ 572 $ 132,981 Held to maturity securities (HTM): Mortgage-backed securities $ 315,135 $ 466 $ 1,474 $ 314,127 $ 319,978 $ 186 $ 2,531 $ 317,633 Trust preferred securities 10,695 495 326 10,864 10,620 522 267 10,875 Municipal securities 35,105 288 4 35,389 35,443 10 783 34,670 Total HTM $ 360,935 $ 1,249 $ 1,804 $ 360,380 $ 366,041 $ 718 $ 3,581 $ 363,178
Investments Classified By Contractual Maturity Date	Available for sale Held to maturity Amortized Fair Amortized Fair (in thousands) cost value cost value Due in one year or less $ 13,456 $ 13,613 $ 867 $ 867 Due after one year through five years 105,969 107,783 24,732 24,978 Due after five years through ten years 23,056 23,813 1,023 1,049 Due after ten years 29,840 32,382 19,178 19,359 Mortgage-backed securities - - 315,135 314,127 $ 172,321 $ 177,591 $ 360,935 $ 360,380
Schedule of Securities in an Unrealized Loss Position	September 30, 2017 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ 716 $ 25 $ 6,829 $ 355 $ 7,545 $ 380 Corporate debt securities 4,612 12 - - 4,612 12 Municipal securities 839 4 - - 839 4 Total AFS $ 6,167 $ 41 $ 6,829 $ 355 $ 12,996 $ 396 HTM Mortgage-backed securities $ 113,570 $ 698 $ 69,354 $ 776 $ 182,924 $ 1,474 Trust preferred securities - - 4,845 326 4,845 326 Municipal securities 3,547 4 - - 3,547 4 Total HTM $ 117,117 $ 702 $ 74,199 $ 1,102 $ 191,316 $ 1,804 December 31, 2016 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ 14,979 $ 526 $ 995 $ 7 $ 15,974 $ 533 Corporate debt securities 14,482 21 - - 14,482 21 Municipal securities 1,214 18 - - 1,214 18 Total AFS $ 30,675 $ 565 $ 995 $ 7 $ 31,670 $ 572 HTM Mortgage-backed securities $ 217,604 $ 2,107 $ 52,332 $ 424 $ 269,936 $ 2,531 Trust preferred securities 4,175 94 700 173 4,875 267 Municipal securities 30,207 783 - - 30,207 783 Total HTM $ 251,986 $ 2,984 $ 53,032 $ 597 $ 305,018 $ 3,581
Schedule Of Other Investments	September 30, December 31, (in thousands) 2017 2016 Bank stocks — at cost $ 9,048 $ 9,192 Investment in statutory trusts — equity method 2,174 2,173 Total $ 11,222 $ 11,365

Loans (Tables)

Loans (Tables)	9 Months Ended
	Sep. 30, 2017
Loans
Schedule Of Loan Portfolio Segments	(in thousands) At September 30, 2017 At December 31, 2016 Commercial $ 1,250,257 $ 1,217,001 Real estate - mortgage 1,259,648 1,171,596 Construction & land 216,737 175,738 Consumer 287,245 266,947 Other 108,437 103,616 Loans held for investment 3,122,324 2,934,898 Allowance for loan losses (36,850) (33,293) Unearned net loan fees (626) (793) Total net loans $ 3,084,848 $ 2,900,812
Schedule Of Major Portfolio Segment And Non Classified And Classified Loan Class	At September 30, 2017 (in thousands) Non-classified Classified Total Commercial Manufacturing $ 88,605 $ 1,369 $ 89,974 Finance and insurance 39,481 475 39,956 Healthcare 150,731 1,954 152,685 Real estate services 117,358 3,456 120,814 Construction 66,868 539 67,407 Public administration 248,957 913 249,870 Other 493,891 35,660 529,551 1,205,891 44,366 1,250,257 Real estate - mortgage Residential & commercial owner-occupied 467,876 6,470 474,346 Residential & commercial investor 784,663 639 785,302 1,252,539 7,109 1,259,648 Construction & land 216,737 - 216,737 Consumer 285,859 1,386 287,245 Other 106,943 1,494 108,437 Total loans held for investment $ 3,067,969 $ 54,355 $ 3,122,324 Unearned net loan fees (626) Net loans held for investment $ 3,121,698 At December 31, 2016 (in thousands) Non-classified Classified Total Commercial Manufacturing $ 96,465 $ 153 $ 96,618 Finance and insurance 49,764 587 50,351 Healthcare 153,468 555 154,023 Real estate services 125,531 513 126,044 Construction 55,471 3,247 58,718 Public administration 254,861 1,136 255,997 Other 437,219 38,031 475,250 1,172,779 44,222 1,217,001 Real estate - mortgage Residential & commercial owner-occupied 469,027 6,496 475,523 Residential & commercial investor 695,170 903 696,073 1,164,197 7,399 1,171,596 Construction & land 172,816 2,922 175,738 Consumer 265,307 1,640 266,947 Other 101,894 1,722 103,616 Total loans held for investment $ 2,876,993 $ 57,905 $ 2,934,898 Unearned net loan fees (793) Net loans held for investment $ 2,934,105
Schedule Of Allowance For Loan Losses	Three months ended September 30, Nine months ended September 30, (in thousands) 2017 2016 2017 2016 Allowance for loan losses, beginning of period Commercial $ 15,749 $ 17,349 $ 15,398 $ 24,215 Real estate - mortgage 12,804 10,281 11,475 10,372 Construction & land 2,484 2,335 1,997 2,111 Consumer 2,561 2,660 2,803 2,592 Other 1,021 786 945 643 Unallocated 1,006 933 675 753 Total 35,625 34,344 33,293 40,686 Provision Commercial $ 437 $ (1,247) $ 829 $ (2,306) Real estate - mortgage (167) 247 998 138 Construction & land 958 (250) 437 (765) Consumer (9) 109 (172) 187 Other (40) 119 36 262 Unallocated (119) (146) 212 34 Total 1,060 (1,168) 2,340 (2,450) Charge-offs Commercial $ - $ (227) $ (222) $ (6,630) Consumer (11) - (97) (20) Other - (4) - (4) Total (11) (231) (319) (6,654) Recoveries Commercial $ 165 $ 460 $ 346 $ 1,056 Real estate - mortgage 3 9 167 27 Construction & land 4 101 1,012 840 Consumer 4 14 11 24 Total 176 584 1,536 1,947 Allowance for loan losses, end of period Commercial $ 16,351 $ 16,335 $ 16,351 $ 16,335 Real estate - mortgage 12,640 10,537 12,640 10,537 Construction & land 3,446 2,186 3,446 2,186 Consumer 2,545 2,783 2,545 2,783 Other 981 901 981 901 Unallocated 887 787 887 787 Total $ 36,850 $ 33,529 $ 36,850 $ 33,529
Schedule Of Loans Held For Investment And ALL On The Basis Of Impairment Method	At September 30, 2017 At December 31, 2016 Individually evaluated for impairment Collectively evaluated for impairment Individually evaluated for impairment Collectively evaluated for impairment (in thousands) Loans Allowance Loans Allowance Loans Allowance Loans Allowance Commercial $ 33,585 $ 3,362 $ 1,218,230 $ 12,989 $ 20,279 $ 2,220 $ 1,197,453 $ 13,178 Real estate - mortgage 2,453 77 1,256,453 12,563 3,758 147 1,167,365 11,328 Construction & land 1,792 122 213,380 3,324 1,919 109 172,532 1,888 Consumer 238 81 287,062 2,464 294 98 266,719 2,705 Other - - 108,505 981 - - 103,786 945 Unallocated - - - 887 - - - 675 Total $ 38,068 $ 3,642 $ 3,083,630 $ 33,208 $ 26,250 $ 2,574 $ 2,907,855 $ 30,719
Schedule Of Impaired Loans	At September 30, 2017 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans allowance allowance allowance Commercial Manufacturing $ 3,342 $ 3,342 $ 3,342 $ - $ 192 Finance and insurance 475 475 475 - 50 Healthcare 528 528 437 91 201 Real estate services 5,123 5,123 5,123 - 287 Construction 1,864 1,864 1,710 154 278 Public administration 320 320 320 - 22 Other 22,273 21,933 20,709 1,224 2,332 33,925 33,585 32,116 1,469 3,362 Real estate - mortgage Residential & commercial owner-occupied 1,172 1,172 869 303 59 Residential & commercial investor 1,281 1,281 1,281 - 18 2,453 2,453 2,150 303 77 Construction & land 1,792 1,792 1,792 - 122 Consumer 238 238 81 157 81 Total $ 38,408 $ 38,068 $ 36,139 $ 1,929 $ 3,642 At December 31, 2016 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans allowance allowance allowance Commercial Manufacturing $ 2,095 $ 2,072 $ 2,071 $ 1 $ 114 Finance and insurance 25 25 25 - 25 Healthcare 189 189 189 - 11 Real estate services 6,268 6,268 6,268 - 350 Construction 2,166 2,166 1,932 234 149 Other 10,716 9,559 9,066 493 1,571 21,459 20,279 19,551 728 2,220 Real estate - mortgage Residential & commercial owner-occupied 1,391 1,391 1,122 269 64 Residential & commercial investor 2,367 2,367 2,367 - 83 3,758 3,758 3,489 269 147 Construction & land 1,919 1,919 1,919 - 109 Consumer 294 294 195 99 98 Total $ 27,430 $ 26,250 $ 25,154 $ 1,096 $ 2,574 Impaired loans Three months ended September 30, Nine months ended September 30, 2017 2016 2017 2016 (in thousands) Average recorded Interest income Average recorded Interest income Average recorded Interest income Average recorded Interest income Commercial Manufacturing $ 2,444 $ 30 $ 3,100 $ 31 $ 2,173 $ 89 $ 3,815 $ 122 Finance and insurance 476 6 28 - 349 16 31 - Healthcare 500 15 205 3 432 29 194 9 Real estate services 5,475 45 7,046 78 5,812 147 7,240 206 Construction 1,524 39 1,998 59 1,591 79 1,694 98 Public administration 106 1 - - 36 1 - - Other 19,998 467 11,598 150 16,421 869 12,861 407 30,523 603 23,975 321 26,814 1,230 25,835 842 Real estate - mortgage Residential & commercial owner-occupied 1,158 8 1,680 18 1,236 26 1,877 43 Residential & commercial investor 1,285 14 3,141 30 2,005 54 4,171 107 2,443 22 4,821 48 3,241 80 6,048 150 Construction & land 1,807 15 2,309 34 1,850 46 2,470 76 Consumer 242 5 243 4 244 7 504 18 Total $ 35,015 $ 645 $ 31,348 $ 407 $ 32,149 $ 1,363 $ 34,857 $ 1,086
Schedule Of Transactions Related To Troubled Debt Restructurings	(in thousands) Performing Nonperforming Total Beginning balance at December 31, 2016 $ 23,612 $ 2,541 $ 26,153 New restructurings 16,031 1,435 17,466 Change in accrual status (98) 98 - Net paydowns (6,340) (956) (7,296) Charge-offs - (41) (41) Ending balance at September 30, 2017 $ 33,205 $ 3,077 $ 36,282
Schedule Of Troubled Debt Restructurings	Three months ended September 30, 2017 Three months ended September 30, 2016 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing 1 $ 1,366 $ 1,366 - $ - $ - Construction - - - 2 1,500 1,444 Other 8 4,617 3,763 4 3,122 2,757 Total 9 $ 5,983 $ 5,129 6 $ 4,622 $ 4,201 Nine months ended September 30, 2017 Nine months ended September 30, 2016 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing 1 $ 1,366 $ 1,366 1 $ 50 $ 23 Finance and insurance 1 456 456 - - - Healthcare 3 465 304 1 100 100 Construction - - - 3 1,825 1,769 Public administration 1 320 320 - - - Other 13 14,472 13,230 8 6,640 5,726 19 17,079 15,676 13 8,615 7,618 Consumer 1 83 75 1 77 73 Total 20 $ 17,162 $ 15,751 14 $ 8,692 $ 7,691
Schedule Of Troubled Debt Restructurings That Subsequently Defaulted	Nine months ended September 30, 2016 Troubled debt restructurings that subsequently defaulted Number of contracts Recorded investment Commercial Other 3 $ 1,586
Schedule Of Nonaccrual Loans	(in thousands) At September 30, 2017 At December 31, 2016 Commercial Manufacturing $ - $ 2 Finance and insurance 19 25 Healthcare 304 - Construction 1,006 234 Other 3,089 1,941 Total commercial 4,418 2,202 Real estate-mortgage Residential & commercial owner-occupied 303 269 Total real estate - mortgage 303 269 Consumer 142 167 Total nonaccrual loans $ 4,863 $ 2,638
Schedule Of Aging Of The Company's Loan Portfolio	At September 30, 2017 30 - 59 60 - 89 90 days or more Days Days 90+ Days Total past due and (in thousands) past due past due past due past due Current Total loans accruing Commercial Manufacturing $ 200 $ - $ - $ 200 $ 89,774 $ 89,974 $ - Finance and insurance 1,451 - - 1,451 38,505 39,956 - Healthcare 459 459 133 1,051 151,634 152,685 - Real estate services 250 - - 250 120,564 120,814 - Construction 438 - 375 813 66,594 67,407 - Public administration - - - - 249,870 249,870 - Other 1,096 3,122 1,024 5,242 524,309 529,551 20 3,894 3,581 1,532 9,007 1,241,250 1,250,257 20 Real estate - mortgage Residential & commercial owner-occupied 5 122 - 127 474,219 474,346 - Residential & commercial investor 892 233 - 1,125 784,177 785,302 - 897 355 - 1,252 1,258,396 1,259,648 - Construction & land - - - - 216,737 216,737 - Consumer 15 1,087 61 1,163 286,082 287,245 - Other - - - - 108,437 108,437 - Total loans held for investment $ 4,806 $ 5,023 $ 1,593 $ 11,422 $ 3,110,902 $ 3,122,324 $ 20 Unearned net loan fees (626) Net loans held for investment $ 3,121,698 At December 31, 2016 Recorded investment in loans 30 - 59 60 - 89 90 days or more Days Days 90+ Days Total past due and (in thousands) past due past due past due past due Current Total loans accruing Commercial Manufacturing $ - $ - $ - $ - $ 96,618 $ 96,618 $ - Finance and insurance 456 - 25 481 49,870 50,351 - Healthcare 500 - - 500 153,523 154,023 - Real estate services - - - - 126,044 126,044 - Construction 260 - - 260 58,458 58,718 - Public administration - - - - 255,997 255,997 - Other 2,941 200 - 3,141 472,109 475,250 - 4,157 200 25 4,382 1,212,619 1,217,001 - Real estate - mortgage Residential & commercial owner-occupied 204 161 - 365 475,158 475,523 - Residential & commercial investor - 225 - 225 695,848 696,073 - 204 386 - 590 1,171,006 1,171,596 - Construction & land - - 657 657 175,081 175,738 657 Consumer 4 63 75 142 266,805 266,947 - Other - - - - 103,616 103,616 - Total loans held for investment $ 4,365 $ 649 $ 757 $ 5,771 $ 2,929,127 $ 2,934,898 $ 657 Unearned net loan fees (793) Net loans held for investment $ 2,934,105

Accumulated Other Comprehensi24

Accumulated Other Comprehensive Income (Tables)	9 Months Ended
	Sep. 30, 2017
Accumulated Other Comprehensive Income
Schedule of reclassifications out of accumulated comprehensive income	Three months ended Nine months ended September 30, September 30, AOCI component (in thousands) 2017 2016 2017 2016 Line item in Condensed Consolidated Statements of Income Available for sale securities: Realized gain (loss) $ (2) $ 98 $ (5) $ 95 Net (gain) loss on securities, other assets and OREO Taxes 1 (37) 2 (36) Provision for income taxes Subtotal (1) 61 (3) 59 Held to maturity securities: Amortization of net unrealized gain on HTM securities 469 459 1,313 1,385 Interest on taxable / nontaxable securities Taxes (178) (174) (497) (526) Provision for income taxes Subtotal 291 285 816 859 Cash flow hedges: Loans 129 151 595 463 Interest and fees on loans Debt (317) (426) (1,014) (1,296) Interest on subordinated debentures and notes payable Realized loss (188) (275) (419) (833) Taxes 71 105 158 317 Provision for income taxes Subtotal (117) (170) (261) (516) Total reclassifications out of AOCI $ 173 $ 176 $ 552 $ 402
Schedule of beginning and ending balances of AOCI and changes during the period	Accumulated other comprehensive income (in thousands) AFS HTM Cash flow hedges Total Balance at December 31, 2016 $ 1,658 $ 3,154 $ (4,246) $ 566 Other comprehensive income (loss) items 1,618 - 114 1,732 Reclassifications 3 (816) 261 (552) Other comprehensive income (loss), net of tax 1,621 (816) 375 1,180 Balance at September 30, 2017 $ 3,279 $ 2,338 $ (3,871) $ 1,746

Derivatives (Tables)

Derivatives (Tables)	9 Months Ended
	Sep. 30, 2017
Derivatives
Schedule Of Derivative Instruments In The Statements Of Financial Position	Asset derivatives Liability derivatives Fair value at Fair value at Balance sheet September 30, December 31, Balance sheet September 30, December 31, (in thousands) classification 2017 2016 classification 2017 2016 Derivatives designated as hedging instruments under ASC 815: Cash flow hedge - interest rate swap Other assets $ - $ - Accrued interest and other liabilities $ 6,584 $ 7,639 Fair value hedge - interest rate swap Other assets $ 400 $ 476 Accrued interest and other liabilities $ 920 $ 845 Derivatives not designated as hedging instruments under ASC 815: Interest rate swap Other assets $ 2,255 $ 2,755 Accrued interest and other liabilities $ 2,349 $ 2,736 Foreign exchange forward contracts Other assets $ 23 $ 52 Accrued interest and other liabilities $ 4 $ 5
Schedule Of Fair Value Of Derivative Financial Instruments And Their Classification On Condensed Consolidated Balance Sheets	At September 30, 2017 Assets Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ 400 $ - $ 400 $ (400) $ - $ - Derivatives not designated as hedges (1) 2,278 - 2,278 (835) - 1,443 Total $ 2,678 $ - $ 2,678 $ (1,235) $ - $ 1,443 At September 30, 2017 Liabilities Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ (7,504) $ - $ (7,504) $ 400 $ 7,104 $ - Derivatives not designated as hedges (2) (2,353) - (2,353) 835 1,452 (66) Securities sold under agreements to repurchase (3) (60,335) - (60,335) - 60,335 - Total $ (70,192) $ - $ (70,192) $ 1,235 $ 68,891 $ (66) At December 31, 2016 Assets Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ 476 $ - $ 476 $ (476) $ - $ - Derivatives not designated as hedges (1) 2,807 - 2,807 (967) - 1,840 Total $ 3,283 $ - $ 3,283 $ (1,443) $ - $ 1,840 At December 31, 2016 Liabilities Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ (8,484) $ - $ (8,484) $ 476 $ 8,008 $ - Derivatives not designated as hedges (2) (2,741) - (2,741) 967 1,668 (106) Securities sold under agreements to repurchase (3) (27,639) - (27,639) - 27,639 - Total $ (38,864) $ - $ (38,864) $ 1,443 $ 37,315 $ (106) (1) Included in other assets. (2) Included in accrued interest and other liabilities. (3) Separately stated in the Condensed Consolidated Balance Sheets.
Schedule Of Notional Amounts Of Outstanding Derivative Positions	(in thousands) Notional Fixed rate Termination date Hedged item - Junior subordinated debentures issued by: CoBiz Statutory Trust I $ 20,000 % March 17, 2022 CoBiz Capital Trust II $ 30,000 % April 23, 2020 CoBiz Capital Trust III $ 20,000 % March 30, 2024

Borrowed Funds (Tables)

Borrowed Funds (Tables)	9 Months Ended
	Sep. 30, 2017
Borrowed Funds
Schedule of short-term borrowings	September 30, December 31, (in thousands) 2017 2016 Securities sold under agreements to repurchase (secured by pledge of mortgage-backed securities with an estimated fair value of $61,542 and $28,192, respectively) $ 60,335 $ 27,639 Other short-term borrowings 101,476 106,230

Employee Benefit and Stock Co27

Employee Benefit and Stock Compensation Plans (Tables)	9 Months Ended
	Sep. 30, 2017
Employee Benefit and Stock Compensation Plans
Summary Of Changes In Option Awards	Weighted average Shares exercise price Outstanding at December 31, 2016 285,999 $ 10.45 Granted 34,500 16.94 Exercised (96,703) 9.80 Forfeited (15,200) 11.99 Outstanding at September 30, 2017 208,596 $ 11.71 Exercisable at September 30, 2017 112,952 $ 10.10
Summary Of Changes In Restricted Stock Awards	Weighted average Shares grant date fair value Unvested at December 31, 2016 467,203 $ 11.50 Granted 199,146 16.99 Vested (253,407) 11.93 Forfeited (8,036) 12.81 Unvested at September 30, 2017 404,906 $ 13.90

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2017
Segments
Summary Of Results Of Operations By Operating Segment	Three months ended September 30, 2017 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ 36,862 $ - $ 85 $ 36,947 Total interest expense 1,327 (1) 1,852 3,178 Provision for loan losses 1,098 - (38) 1,060 Noninterest income 3,777 4,888 330 8,995 Noninterest expense 8,658 4,237 13,497 26,392 Management fees and allocations, net of tax 7,881 290 (8,171) - Provision (benefit) for income taxes 9,661 239 (5,781) 4,119 Net income (loss) $ 12,014 $ 123 $ (944) $ 11,193 Nine months ended September 30, 2017 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ 105,176 $ 1 $ 257 $ 105,434 Total interest expense 4,085 13 5,484 9,582 Provision for loan losses 2,472 - (132) 2,340 Noninterest income 10,447 14,468 719 25,634 Noninterest expense 26,222 13,003 40,936 80,161 Management fees and allocations, net of tax 23,930 882 (24,812) - Provision (benefit) for income taxes 26,423 511 (17,245) 9,689 Net income (loss) $ 32,491 $ 60 $ (3,255) $ 29,296 Three months ended September 30, 2016 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ 32,216 $ - $ 92 $ 32,308 Total interest expense 1,078 11 1,818 2,907 Provision for loan losses (1,158) - (10) (1,168) Noninterest income 3,622 4,536 1,128 9,286 Noninterest expense 9,731 4,055 12,257 26,043 Management fees and allocations, net of tax 7,757 464 (8,221) - Provision (benefit) for income taxes 7,535 165 (4,157) 3,543 Net income (loss) $ 10,895 $ (159) $ (467) $ 10,269 Nine months ended September 30, 2016 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ 94,727 $ 1 $ 275 $ 95,003 Total interest expense 3,369 25 5,446 8,840 Provision for loan losses (2,300) - (150) (2,450) Noninterest income 9,318 13,578 1,890 24,786 Noninterest expense 27,715 12,807 37,621 78,143 Management fees and allocations, net of tax 23,831 1,255 (25,086) - Provision (benefit) for income taxes 21,888 277 (13,075) 9,090 Net income (loss) $ 29,542 $ (785) $ (2,591) $ 26,166

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2017
Fair Value Measurements
Financial Assets And Liabilities Measured At Fair Value On Recurring Basis	Fair value measurements using: Quoted prices in Significant Significant active markets for observable unobservable Balance at identical assets inputs inputs (in thousands) September 30, 2017 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ 38,691 $ 4,433 $ 25,091 $ 9,167 Corporate debt securities 135,590 - 135,590 - Municipal securities 3,310 - 3,310 - Total available for sale securities $ 177,591 $ 4,433 $ 163,991 $ 9,167 Derivatives: Fair value hedges $ 400 $ - $ 400 $ - Non-designated hedges 2,255 - 2,255 - Foreign exchange forward contracts 23 - 23 - Total derivative assets $ 2,678 $ - $ 2,678 $ - Liabilities Derivatives: Cash flow hedges $ 6,584 $ - $ 6,584 $ - Fair value hedges 920 - 920 - Non-designated hedges 2,349 - 2,349 - Foreign exchange forward contracts 4 - 4 - Total derivative liabilities $ 9,857 $ - $ 9,857 $ - Fair value measurements using: Quoted prices in Significant Significant active markets for observable unobservable Balance at identical assets inputs inputs (in thousands) December 31, 2016 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ 37,624 $ 4,283 $ 23,893 $ 9,448 Corporate debt securities 92,077 - 92,077 - Municipal securities 3,280 - 3,280 - Total available for sale securities $ 132,981 $ 4,283 $ 119,250 $ 9,448 Derivatives: Fair value hedges $ 476 $ - $ 476 $ - Non-designated hedges 2,755 - 2,755 - Foreign exchange forward contracts 52 - 52 - Total derivative assets $ 3,283 $ - $ 3,283 $ - Liabilities Derivatives: Cash flow hedges $ 7,639 $ - $ 7,639 $ - Fair value hedge 845 - 845 - Non-designated hedges 2,736 - 2,736 - Foreign exchange forward contracts 5 - 5 - Total derivative liabilities $ 11,225 $ - $ 11,225 $ -
Reconciliation Of Financial Assets Measured At Fair Value On Recurring Basis Using Significant Unobservable Inputs	Three months ended Nine months ended September 30, September 30, (in thousands) 2017 2016 2017 2016 Beginning balance $ 10,198 $ 8,955 $ 9,448 $ 5,810 Transfers and purchases - - - 3,276 Net accretion 28 29 87 60 Sales / calls / maturities (1,000) - (1,000) - Unrealized gain (loss) included in comprehensive income (59) 291 632 129 Ending balance $ 9,167 $ 9,275 $ 9,167 $ 9,275
Schedule Of Assets Measured At Fair Value On A Nonrecurring Basis	Fair value measurements using: Quoted prices in Significant Significant active markets for observable unobservable identical assets inputs inputs (in thousands) Total (Level 1) (Level 2) (Level 3) At September 30, 2017 Impaired loans $ 2,969 $ - $ - $ 2,969 OREO $ 5,351 $ - $ - $ 5,351 At December 31, 2016 Impaired loans $ 1,425 $ - $ - $ 1,425 OREO $ 5,351 $ - $ - $ 5,351
Schedule of Gains And Losses Recorded In Relation To Assets And Liabilities Measured On Nonrecurring Basis	Gain for the three months ended Gain for the nine months ended September 30, September 30, (in thousands) 2017 2016 2017 2016 Impaired loans $ 38 $ 975 $ 1,009 $ 3,149
Reconciliation Of Other Real Estate Owned Fair Value Measurement	At At (in thousands) September 30, 2017 December 31, 2016 OREO recorded at fair value $ 5,351 $ 5,351 Estimated selling costs (272) (272) OREO $ 5,079 $ 5,079
Fair Value Measurements, Recurring And Nonrecurring, Valuation Techniques	At September 30, 2017 Fair value Weighted Category (in thousands) Valuation technique Unobservable input average Range Trust preferred securities $ 9,167 Market approach Discount to carrying value using broker quotes or observable prices on similar securities 7 % 5% to 13% Impaired loans: Commercial $ 2,509 Sales comparison (1) Management discount for asset type 53 % 0% - 90% Real estate - mortgage 303 Sales comparison (2) Sales comparison adjustments (2) % (1)% - (4)% Consumer 157 Sales comparison (2) Sales comparison adjustments (36) % (13)% - (59)% Total impaired loans $ 2,969 OREO: Commercial $ 190 Property appraisals (2) Management discount for property type 0 % NA Construction & land 5,161 Property appraisals (2) Management discount for property type 17 % NA Total OREO $ 5,351 At December 31, 2016 Fair value Weighted Category (in thousands) Valuation technique Unobservable input average Range Trust preferred securities $ 9,448 Market approach Discount to carrying value using broker quotes or observable prices on similar securities 13 % 1% to 28% Impaired loans: Commercial $ 1,057 Sales comparison (1) Management discount for asset type 59 % 0% to 76% Real estate - mortgage 269 Sales comparison (2) Sales comparison adjustments 18 % NA Consumer 99 Sales comparison (2) Sales comparison adjustments (1) % (11)% to 10% Total impaired loans $ 1,425 OREO: Commercial $ 190 Property appraisals (2) Management discount for property type 0 % 0% Construction & land 5,161 Property appraisals (2) Management discount for property type 17 % NA Total OREO $ 5,351 (1) Discount represents management’s discounts applied to market valuation of various business asset types including accounts receivable and other commercial assets. (2) The fair value of OREO and collateral-dependent impaired loans is based on third-party property appraisals. The majority of the appraisals utilize at least two valuation approaches or a combination of approaches including a market approach, where prices and other relevant information generated by market transactions involving similar or comparable properties are used to determine fair value. Appraisals may include an ‘as is’ and ‘upon completion’ valuation approach. Adjustments are routinely made in the appraisal process by third-party appraisers to adjust for differences between the comparable sales and income data. Adjustments also result from the consideration of relevant economic and demographic factors with the potential to affect property values. Also, prospective values are based on the market conditions which exist at the date of inspection combined with informed forecasts based on current trends in supply and demand for the property types under appraisal. Positive adjustments disclosed in these tables represent increases and negative adjustments represent decreases in fair value.
Schedule Of Estimated Fair Value Of Financial Instruments	September 30, 2017 December 31, 2016 Carrying Estimated Carrying Estimated (in thousands) value fair value value fair value Financial assets: Cash and cash equivalents $ 79,305 $ 79,305 $ 96,050 $ 96,050 Investment securities available for sale 177,591 177,591 132,981 132,981 Investment securities held to maturity 360,935 360,380 366,041 363,178 Other investments 2,174 2,174 2,173 2,173 Loans — net 3,084,848 3,080,579 2,900,812 2,868,091 Accrued interest receivable 13,698 13,698 12,223 12,223 Derivatives 2,678 2,678 3,283 3,283 Financial liabilities: Deposits $ 3,177,532 $ 3,176,777 $ 3,029,783 $ 3,029,226 Securities sold under agreements to repurchase 60,335 56,667 27,639 26,101 Other short-term borrowings 101,476 101,476 106,230 106,230 Accrued interest payable 1,876 1,876 1,038 1,038 Subordinated notes payable 59,173 58,983 59,111 58,681 Junior subordinated debentures 72,166 72,166 72,166 72,166 Derivatives 9,857 9,857 11,225 11,225

Regulatory Matters (Tables)

Regulatory Matters (Tables)	9 Months Ended
	Sep. 30, 2017
Regulatory Matters
Schedule Of Regulatory Capital Ratios Of The Company And The Bank	At September 30, 2017 Capitalized Ratio Bank Company Minimum ratio (in thousands) Ratios Ratios Well (1) plus fully phased-in CCB Common equity tier 1 capital 12.0 % 10.0 % 6.5 % % Tier 1 capital 12.0 % 11.6 % 8.0 % % Total capital 13.1 % 14.5 % 10.0 % % Tier 1 leverage 10.4 % 10.0 % 5.0 % % (1) The ratios for the well-capitalized requirement are only applicable to the Bank. However, the Company manages its capital position as if the requirement applies to the consolidated entity and has presented the ratios as if they also applied to the Company.

Supplemental Financial Data (Ta

Supplemental Financial Data (Tables)	9 Months Ended
	Sep. 30, 2017
Supplemental Financial Data
Schedule Of Other Income And Other Expense	Three months ended Nine months ended Other noninterest income September 30, September 30, (in thousands) 2017 2016 2017 2016 Loan fees $ 953 $ 795 $ 1,816 $ 1,737 Other customer service fees 741 694 2,163 2,023 Bank-owned life insurance 356 345 1,015 1,000 Other investments 355 1,348 1,102 2,262 Derivative valuation (35) - (172) (456) Other 77 15 123 134 Total $ 2,447 $ 3,197 $ 6,047 $ 6,700 Three months ended Nine months ended Other noninterest expense September 30, September 30, (in thousands) 2017 2016 2017 2016 Marketing and business development $ 603 $ 559 $ 1,991 $ 2,104 Service contracts 1,374 1,331 4,095 3,855 Professional fees 923 824 2,621 2,135 Office supplies and delivery 313 336 894 972 Other 540 947 2,408 2,861 Total $ 3,753 $ 3,997 $ 12,009 $ 11,927

Nature of Operations and Sign32

Nature of Operations and Significant Accounting Policies - Organization (Details)	9 Months Ended
	Sep. 30, 2017location
Denver, Colorado
Organization
Number of branches	7
Boulder, Colorado
Organization
Number of branches	1
Vail, Colorado
Organization
Number of branches	1
Colorado Springs, Colorado
Organization
Number of branches	1
Fort Collins, Colorado
Organization
Number of branches	1
Phoenix, Arizona
Organization
Number of branches	4

Nature of Operations and Sign33

Nature of Operations and Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Oct. 20, 2017	Dec. 31, 2016
Supplemental disclosure of certain cash and cash equivalents
Interest	$ 8,745	$ 8,141
Income taxes	8,112	5,538
Loans transferred to held for sale		$ 60
Lessor-paid tenant improvement allowance	358
Investments
Trading Securities	$ 0			$ 0
Impaired loans
Impaired Loans, Threshold for payment shortfall to be considered for impairment, percentage of contractual payment	10.00%
Tarp Warrant
Warrant
Warrant term (in years)	10 years
Number of shares issuable under warrant terms	895,968
Exercise price per share	$ 10.79
Common stock issued in full settlement of warrant			432,299

Recent Accounting Pronounceme34

Recent Accounting Pronouncements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2016
Accounting Standards Update 2016-02 | Forecast
Recent Accounting Pronouncements
Future operating lease obligations	$ 30.4
Fee-Based Lines
Recent Accounting Pronouncements
Revenues		$ 18.3

Earnings per Common Share - Sch

Earnings per Common Share - Schedule of Weighted Average Shares Outstanding Used in Calculation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Earnings per Common Share and Dividends Declared per Common Share
Net income available to common shareholders	$ 11,193	$ 10,269	$ 29,296	$ 26,166
Dividends and undistributed earnings allocated to participating securities	(109)	(116)	(296)	(300)
Earnings allocated to common shares	$ 11,084	$ 10,153	$ 29,000	$ 25,866
Weighted average common shares - issued	41,783,604	41,434,195	41,713,831	41,334,632
Average unvested restricted share awards	(406,406)	(462,927)	(421,174)	(472,885)
Weighted average common shares outstanding - basic	41,377,198	40,971,268	41,292,657	40,861,747
Effect of dilutive stock options and awards outstanding	404,218	220,779	400,977	180,676
Weighted average common shares outstanding - diluted	41,781,416	41,192,047	41,693,634	41,042,423
Weighted average antidilutive securities outstanding	41,101	118,596	27,336	158,154
Basic earnings per common share	$ 0.27	$ 0.25	$ 0.70	$ 0.63
Diluted earnings per common share	0.27	0.25	0.70	0.63
Dividends declared per share	$ 0.055	$ 0.050	$ 0.155	$ 0.140

Investments - Reconciliation fr

Investments - Reconciliation from Amortized Cost to Fair Value of Investment Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Available for sale securities (AFS):
Amortized cost	$ 172,321	$ 130,308
Gross unrealized gains	5,666	3,245
Gross unrealized losses	396	572
Fair value	177,591	132,981
Held to maturity securities (HTM):
Amortized cost	360,935	366,041
Gross unrealized gains	1,249	718
Gross unrealized losses	1,804	3,581
Fair value	360,380	363,178
Mortgage-backed securities
Held to maturity securities (HTM):
Amortized cost	315,135	319,978
Gross unrealized gains	466	186
Gross unrealized losses	1,474	2,531
Fair value	314,127	317,633
Trust preferred securities
Available for sale securities (AFS):
Amortized cost	35,607	36,450
Gross unrealized gains	3,464	1,707
Gross unrealized losses	380	533
Fair value	38,691	37,624
Held to maturity securities (HTM):
Amortized cost	10,695	10,620
Gross unrealized gains	495	522
Gross unrealized losses	326	267
Fair value	10,864	10,875
Corporate debt securities
Available for sale securities (AFS):
Amortized cost	133,460	90,593
Gross unrealized gains	2,142	1,505
Gross unrealized losses	12	21
Fair value	135,590	92,077
Municipal securities
Available for sale securities (AFS):
Amortized cost	3,254	3,265
Gross unrealized gains	60	33
Gross unrealized losses	4	18
Fair value	3,310	3,280
Held to maturity securities (HTM):
Amortized cost	35,105	35,443
Gross unrealized gains	288	10
Gross unrealized losses	4	783
Fair value	$ 35,389	$ 34,670

Investments - Schedule of Amort

Investments - Schedule of Amortized Cost and Estimated Fair Value of Investment Securities by Contractual Maturities (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Available-for-sale, Amortized cost
Available for sale securities, Amortized cost, Due in one year or less	$ 13,456
Available for sale securities, Amortized cost, Due after one year through five years	105,969
Available for sale securities, Amortized cost, Due after five years through ten years	23,056
Available for sale securities, Amortized cost, Due after ten years	29,840
Available for sale securities, Amortized cost, Amortized cost	172,321
Available-for-sale, Fair value
Available for sale securities, Estimated fair value, Due in one year or less	13,613
Available for sale securities, Estimated fair value, Due after one year through five years	107,783
Available for sale securities, Estimated fair value, Due after five years through ten years	23,813
Available for sale securities, Estimated fair value, Due after ten years	32,382
Fair value	177,591	$ 132,981
Held-to-maturity, Amortized cost
Held to maturity securities, Amortized cost, Due in one year or less	867
Held to maturity securities, Amortized cost, Due after one year through five years	24,732
Held to maturity securities, Amortized cost, Due after five years through ten years	1,023
Held to maturity securities, Amortized cost, Due after ten years	19,178
Held to maturity securities, Amortized cost, Mortgage-backed securities	315,135
Held-to-maturity Securities, Total	360,935	366,041
Held-to-maturity, Fair value
Held to maturity securities, Estimated fair value, Due in one year or less	867
Held to maturity securities, Estimated fair value, Due after one year through five years	24,978
Held to maturity securities, Estimated fair value, Due after five years through ten years	1,049
Held to maturity securities, Estimated fair value, Due after ten years	19,359
Held to maturity securities, Estimated fair value, Mortgage-backed securities	314,127
Fair value	$ 360,380	$ 363,178

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Investments
Investment securities pledged to secure public deposits	$ 175.2	$ 143.6
Public deposits	$ 129.9	$ 95.8

Investments - Schedule of Secur

Investments - Schedule of Securities Related to Unrecognized OTTI (Details) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2017USD ($)security	Dec. 31, 2016USD ($)security
Securities in Continuous Unrealized Loss Positions
Number of credit-impaired securities | security	0	0
Securities in unrealized loss position | security	130	165
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	$ 6,167	$ 30,675
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	6,829	995
Available for sale securities in continuous unrealized loss position, Fair Value	12,996	31,670
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	41	565
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	355	7
Available for sale securities in continuous unrealized loss position, Unrealized loss	396	572
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	117,117	251,986
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	74,199	53,032
HTM securities in continuous unrealized loss position, Fair Value, Total	191,316	305,018
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	702	2,984
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	1,102	597
HTM securities in continuous unrealized loss position, Unrealized loss, Total	1,804	3,581
Mortgage-backed securities
Securities in Continuous Unrealized Loss Positions
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	113,570	217,604
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	69,354	52,332
HTM securities in continuous unrealized loss position, Fair Value, Total	182,924	269,936
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	698	2,107
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	776	424
HTM securities in continuous unrealized loss position, Unrealized loss, Total	1,474	2,531
Trust preferred securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	716	14,979
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	6,829	995
Available for sale securities in continuous unrealized loss position, Fair Value	7,545	15,974
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	25	526
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	355	7
Available for sale securities in continuous unrealized loss position, Unrealized loss	380	533
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months		4,175
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	4,845	700
HTM securities in continuous unrealized loss position, Fair Value, Total	4,845	4,875
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months		94
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	326	173
HTM securities in continuous unrealized loss position, Unrealized loss, Total	326	267
Corporate debt securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	4,612	14,482
Available for sale securities in continuous unrealized loss position, Fair Value	4,612	14,482
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	12	21
Available for sale securities in continuous unrealized loss position, Unrealized loss	12	21
Municipal securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	839	1,214
Available for sale securities in continuous unrealized loss position, Fair Value	839	1,214
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	4	18
Available for sale securities in continuous unrealized loss position, Unrealized loss	4	18
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	3,547	30,207
HTM securities in continuous unrealized loss position, Fair Value, Total	3,547	30,207
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	4	783
HTM securities in continuous unrealized loss position, Unrealized loss, Total	$ 4	$ 783

Investments - Schedule of Other

Investments - Schedule of Other Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Investments
Bank stocks - at cost	$ 9,048	$ 9,192
Investment in statutory trusts - equity method	2,174	2,173
Total	$ 11,222	$ 11,365

Loans - Schedule of Loan Portfo

Loans - Schedule of Loan Portfolio Segments (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Dec. 31, 2015
Loan portfolio segments
Loans held for investment	$ 3,122,324		$ 2,934,898
Allowance for loan losses	(36,850)	$ (35,625)	(33,293)	$ (33,529)	$ (34,344)	$ (40,686)
Unearned net loan fees	(626)		(793)
Total net loans	3,084,848		2,900,812
Commercial
Loan portfolio segments
Loans held for investment	1,250,257		1,217,001
Allowance for loan losses	(16,351)	(15,749)	(15,398)	(16,335)	(17,349)	(24,215)
Real estate - mortgage
Loan portfolio segments
Loans held for investment	1,259,648		1,171,596
Allowance for loan losses	(12,640)	(12,804)	(11,475)	(10,537)	(10,281)	(10,372)
Construction and land
Loan portfolio segments
Loans held for investment	216,737		175,738
Allowance for loan losses	(3,446)	(2,484)	(1,997)	(2,186)	(2,335)	(2,111)
Consumer
Loan portfolio segments
Loans held for investment	287,245		266,947
Allowance for loan losses	(2,545)	(2,561)	(2,803)	(2,783)	(2,660)	(2,592)
Other
Loan portfolio segments
Loans held for investment	108,437		103,616
Allowance for loan losses	$ (981)	$ (1,021)	$ (945)	$ (901)	$ (786)	$ (643)

Loans - Schedule of Major Portf

Loans - Schedule of Major Portfolio Segment and Non-Classified and Classified Loan Class (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Loan portfolio segments
Loans held for investment	$ 3,122,324	$ 2,934,898
Unearned net loan fees	(626)	(793)
Total loans	3,121,698	2,934,105
Non-classified
Loan portfolio segments
Loans held for investment	3,067,969	2,876,993
Classified
Loan portfolio segments
Loans held for investment	54,355	57,905
Commercial
Loan portfolio segments
Loans held for investment	1,250,257	1,217,001
Commercial | Non-classified
Loan portfolio segments
Loans held for investment	1,205,891	1,172,779
Commercial | Classified
Loan portfolio segments
Loans held for investment	44,366	44,222
Commercial | Manufacturing
Loan portfolio segments
Loans held for investment	89,974	96,618
Commercial | Manufacturing | Non-classified
Loan portfolio segments
Loans held for investment	88,605	96,465
Commercial | Manufacturing | Classified
Loan portfolio segments
Loans held for investment	1,369	153
Commercial | Finance and insurance
Loan portfolio segments
Loans held for investment	39,956	50,351
Commercial | Finance and insurance | Non-classified
Loan portfolio segments
Loans held for investment	39,481	49,764
Commercial | Finance and insurance | Classified
Loan portfolio segments
Loans held for investment	475	587
Commercial | Health care
Loan portfolio segments
Loans held for investment	152,685	154,023
Commercial | Health care | Non-classified
Loan portfolio segments
Loans held for investment	150,731	153,468
Commercial | Health care | Classified
Loan portfolio segments
Loans held for investment	1,954	555
Commercial | Real estate services
Loan portfolio segments
Loans held for investment	120,814	126,044
Commercial | Real estate services | Non-classified
Loan portfolio segments
Loans held for investment	117,358	125,531
Commercial | Real estate services | Classified
Loan portfolio segments
Loans held for investment	3,456	513
Commercial | Construction
Loan portfolio segments
Loans held for investment	67,407	58,718
Commercial | Construction | Non-classified
Loan portfolio segments
Loans held for investment	66,868	55,471
Commercial | Construction | Classified
Loan portfolio segments
Loans held for investment	539	3,247
Commercial | Wholesale and retail trade
Loan portfolio segments
Loans held for investment	249,870	255,997
Commercial | Wholesale and retail trade | Non-classified
Loan portfolio segments
Loans held for investment	248,957	254,861
Commercial | Wholesale and retail trade | Classified
Loan portfolio segments
Loans held for investment	913	1,136
Commercial | Commercial - Other
Loan portfolio segments
Loans held for investment	529,551	475,250
Commercial | Commercial - Other | Non-classified
Loan portfolio segments
Loans held for investment	493,891	437,219
Commercial | Commercial - Other | Classified
Loan portfolio segments
Loans held for investment	35,660	38,031
Real estate - mortgage
Loan portfolio segments
Loans held for investment	1,259,648	1,171,596
Real estate - mortgage | Residential and commercial owner-occupied
Loan portfolio segments
Loans held for investment	474,346	475,523
Real estate - mortgage | Residential and commercial investor
Loan portfolio segments
Loans held for investment	785,302	696,073
Real estate - mortgage | Non-classified
Loan portfolio segments
Loans held for investment	1,252,539	1,164,197
Real estate - mortgage | Non-classified | Residential and commercial owner-occupied
Loan portfolio segments
Loans held for investment	467,876	469,027
Real estate - mortgage | Non-classified | Residential and commercial investor
Loan portfolio segments
Loans held for investment	784,663	695,170
Real estate - mortgage | Classified
Loan portfolio segments
Loans held for investment	7,109	7,399
Real estate - mortgage | Classified | Residential and commercial owner-occupied
Loan portfolio segments
Loans held for investment	6,470	6,496
Real estate - mortgage | Classified | Residential and commercial investor
Loan portfolio segments
Loans held for investment	639	903
Construction and land
Loan portfolio segments
Loans held for investment	216,737	175,738
Construction and land | Non-classified
Loan portfolio segments
Loans held for investment	216,737	172,816
Construction and land | Classified
Loan portfolio segments
Loans held for investment		2,922
Consumer
Loan portfolio segments
Loans held for investment	287,245	266,947
Consumer | Non-classified
Loan portfolio segments
Loans held for investment	285,859	265,307
Consumer | Classified
Loan portfolio segments
Loans held for investment	1,386	1,640
Other
Loan portfolio segments
Loans held for investment	108,437	103,616
Other | Non-classified
Loan portfolio segments
Loans held for investment	106,943	101,894
Other | Classified
Loan portfolio segments
Loans held for investment	$ 1,494	$ 1,722

Loans - Schedule of Allowance f

Loans - Schedule of Allowance for Loan Losses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Allowance for loan losses
Allowance for loan losses, beginning of period	$ 35,625	$ 34,344	$ 33,293	$ 40,686
Provision	1,060	(1,168)	2,340	(2,450)
Charge-offs	(11)	(231)	(319)	(6,654)
Net recoveries of impaired loans	176	584	1,536	1,947
Allowance for loan losses, end of period	36,850	33,529	36,850	33,529
Commercial
Allowance for loan losses
Allowance for loan losses, beginning of period	15,749	17,349	15,398	24,215
Provision	437	(1,247)	829	(2,306)
Charge-offs		(227)	(222)	(6,630)
Net recoveries of impaired loans	165	460	346	1,056
Allowance for loan losses, end of period	16,351	16,335	16,351	16,335
Real estate - mortgage
Allowance for loan losses
Allowance for loan losses, beginning of period	12,804	10,281	11,475	10,372
Provision	(167)	247	998	138
Net recoveries of impaired loans	3	9	167	27
Allowance for loan losses, end of period	12,640	10,537	12,640	10,537
Construction and land
Allowance for loan losses
Allowance for loan losses, beginning of period	2,484	2,335	1,997	2,111
Provision	958	(250)	437	(765)
Net recoveries of impaired loans	4	101	1,012	840
Allowance for loan losses, end of period	3,446	2,186	3,446	2,186
Consumer
Allowance for loan losses
Allowance for loan losses, beginning of period	2,561	2,660	2,803	2,592
Provision	(9)	109	(172)	187
Charge-offs	(11)		(97)	(20)
Net recoveries of impaired loans	4	14	11	24
Allowance for loan losses, end of period	2,545	2,783	2,545	2,783
Other
Allowance for loan losses
Allowance for loan losses, beginning of period	1,021	786	945	643
Provision	(40)	119	36	262
Charge-offs		(4)		(4)
Allowance for loan losses, end of period	981	901	981	901
Unallocated
Allowance for loan losses
Allowance for loan losses, beginning of period	1,006	933	675	753
Provision	(119)	(146)	212	34
Allowance for loan losses, end of period	$ 887	$ 787	$ 887	$ 787

Loans - Schedule of Loans Held

Loans - Schedule of Loans Held for Investment and ALL on the basis of Impairment Method (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	$ 38,068	$ 26,250
Allowance for loan losses, Individually evaluated for impairment	3,642	2,574
Loans held for investment, Collectively evaluated for impairment	3,083,630	2,907,855
Allowance for loan losses, Collectively evaluated for impairment	33,208	30,719
Commercial
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	33,585	20,279
Allowance for loan losses, Individually evaluated for impairment	3,362	2,220
Loans held for investment, Collectively evaluated for impairment	1,218,230	1,197,453
Allowance for loan losses, Collectively evaluated for impairment	12,989	13,178
Real estate - mortgage
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	2,453	3,758
Allowance for loan losses, Individually evaluated for impairment	77	147
Loans held for investment, Collectively evaluated for impairment	1,256,453	1,167,365
Allowance for loan losses, Collectively evaluated for impairment	12,563	11,328
Construction and land
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	1,792	1,919
Allowance for loan losses, Individually evaluated for impairment	122	109
Loans held for investment, Collectively evaluated for impairment	213,380	172,532
Allowance for loan losses, Collectively evaluated for impairment	3,324	1,888
Consumer
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	238	294
Allowance for loan losses, Individually evaluated for impairment	81	98
Loans held for investment, Collectively evaluated for impairment	287,062	266,719
Allowance for loan losses, Collectively evaluated for impairment	2,464	2,705
Other
Allowance for loan losses
Loans held for investment, Collectively evaluated for impairment	108,505	103,786
Allowance for loan losses, Collectively evaluated for impairment	981	945
Unallocated
Allowance for loan losses
Allowance for loan losses, Collectively evaluated for impairment	$ 887	$ 675

Loans - Schedule of Impaired Lo

Loans - Schedule of Impaired Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Impaired receivables with and without related allowance
Unpaid principal balance	$ 38,408	$ 27,430
Recorded investment on impaired loans	38,068	26,250
Recorded investment with a related allowance	36,139	25,154
Recorded investment with no related allowance	1,929	1,096
Related allowance	3,642	2,574
Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	33,925	21,459
Recorded investment on impaired loans	33,585	20,279
Recorded investment with a related allowance	32,116	19,551
Recorded investment with no related allowance	1,469	728
Related allowance	3,362	2,220
Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	2,453	3,758
Recorded investment on impaired loans	2,453	3,758
Recorded investment with a related allowance	2,150	3,489
Recorded investment with no related allowance	303	269
Related allowance	77	147
Construction and land
Impaired receivables with and without related allowance
Unpaid principal balance	1,792	1,919
Recorded investment on impaired loans	1,792	1,919
Recorded investment with a related allowance	1,792	1,919
Related allowance	122	109
Consumer
Impaired receivables with and without related allowance
Unpaid principal balance	238	294
Recorded investment on impaired loans	238	294
Recorded investment with a related allowance	81	195
Recorded investment with no related allowance	157	99
Related allowance	81	98
Manufacturing | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	3,342	2,095
Recorded investment on impaired loans	3,342	2,072
Recorded investment with a related allowance	3,342	2,071
Recorded investment with no related allowance		1
Related allowance	192	114
Finance and insurance | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	475	25
Recorded investment on impaired loans	475	25
Recorded investment with a related allowance	475	25
Related allowance	50	25
Health care | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	528	189
Recorded investment on impaired loans	528	189
Recorded investment with a related allowance	437	189
Recorded investment with no related allowance	91
Related allowance	201	11
Real estate services | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	5,123	6,268
Recorded investment on impaired loans	5,123	6,268
Recorded investment with a related allowance	5,123	6,268
Related allowance	287	350
Construction | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	1,864	2,166
Recorded investment on impaired loans	1,864	2,166
Recorded investment with a related allowance	1,710	1,932
Recorded investment with no related allowance	154	234
Related allowance	278	149
Public administration | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	320
Recorded investment on impaired loans	320
Recorded investment with a related allowance	320
Related allowance	22
Commercial - Other | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	22,273	10,716
Recorded investment on impaired loans	21,933	9,559
Recorded investment with a related allowance	20,709	9,066
Recorded investment with no related allowance	1,224	493
Related allowance	2,332	1,571
Residential and commercial owner-occupied | Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	1,172	1,391
Recorded investment on impaired loans	1,172	1,391
Recorded investment with a related allowance	869	1,122
Recorded investment with no related allowance	303	269
Related allowance	59	64
Residential and commercial investor | Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	1,281	2,367
Recorded investment on impaired loans	1,281	2,367
Recorded investment with a related allowance	1,281	2,367
Related allowance	$ 18	$ 83

Loans - Schedule of Impaired 46

Loans - Schedule of Impaired Loans (Average Recorded Investment in Impaired Loans and Interest Income Recognized) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	$ 35,015	$ 31,348	$ 32,149	$ 34,857
Interest income recognized	645	407	1,363	1,086
Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	30,523	23,975	26,814	25,835
Interest income recognized	603	321	1,230	842
Real estate - mortgage
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	2,443	4,821	3,241	6,048
Interest income recognized	22	48	80	150
Construction and land
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	1,807	2,309	1,850	2,470
Interest income recognized	15	34	46	76
Consumer
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	242	243	244	504
Interest income recognized	5	4	7	18
Manufacturing | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	2,444	3,100	2,173	3,815
Interest income recognized	30	31	89	122
Finance and insurance | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	476	28	349	31
Interest income recognized	6		16
Health care | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	500	205	432	194
Interest income recognized	15	3	29	9
Real estate services | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	5,475	7,046	5,812	7,240
Interest income recognized	45	78	147	206
Construction | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	1,524	1,998	1,591	1,694
Interest income recognized	39	59	79	98
Public administration | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	106		36
Interest income recognized	1		1
Commercial - Other | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	19,998	11,598	16,421	12,861
Interest income recognized	467	150	869	407
Residential and commercial owner-occupied | Real estate - mortgage
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	1,158	1,680	1,236	1,877
Interest income recognized	8	18	26	43
Residential and commercial investor | Real estate - mortgage
Impaired Loans: Average recorded investment and interest income
Average recorded investment in impaired loans	1,285	3,141	2,005	4,171
Interest income recognized	$ 14	$ 30	$ 54	$ 107

Loans - Schedule of Transaction

Loans - Schedule of Transactions Related to Troubled Debt Restructurings (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2017USD ($)
Troubled debt restructurings
Beginning balance	$ 26,153
New restructurings	17,466
Net paydowns	(7,296)
Charge-offs	(41)
Ending balance	36,282
Performing
Troubled debt restructurings
Beginning balance	23,612
New restructurings	16,031
Change in accrual status	(98)
Net paydowns	(6,340)
Ending balance	33,205
Nonperforming
Troubled debt restructurings
Beginning balance	2,541
New restructurings	1,435
Change in accrual status	98
Net paydowns	(956)
Charge-offs	(41)
Ending balance	$ 3,077

Loans - Schedule of Troubled De

Loans - Schedule of Troubled Debt Restructurings (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017USD ($)contract	Sep. 30, 2016USD ($)contract	Sep. 30, 2017USD ($)contract	Sep. 30, 2016USD ($)contract
Troubled debt restructurings
Number of contracts | contract	9	6	20	14
Pre-modification outstanding recorded investment	$ 5,983	$ 4,622	$ 17,162	$ 8,692
Post-modification outstanding recorded investment	5,129	4,201	15,751	7,691
Charge-offs	$ 0	$ 0	$ 0	$ 0
Commercial
Troubled debt restructurings
Number of contracts | contract			19	13
Pre-modification outstanding recorded investment			$ 17,079	$ 8,615
Post-modification outstanding recorded investment			$ 15,676	$ 7,618
Consumer
Troubled debt restructurings
Number of contracts | contract			1	1
Pre-modification outstanding recorded investment			$ 83	$ 77
Post-modification outstanding recorded investment			$ 75	$ 73
Manufacturing | Commercial
Troubled debt restructurings
Number of contracts | contract	1		1	1
Pre-modification outstanding recorded investment	$ 1,366		$ 1,366	$ 50
Post-modification outstanding recorded investment	$ 1,366		$ 1,366	$ 23
Finance and insurance | Commercial
Troubled debt restructurings
Number of contracts | contract			1
Pre-modification outstanding recorded investment			$ 456
Post-modification outstanding recorded investment			$ 456
Health care | Commercial
Troubled debt restructurings
Number of contracts | contract			3	1
Pre-modification outstanding recorded investment			$ 465	$ 100
Post-modification outstanding recorded investment			$ 304	$ 100
Construction | Commercial
Troubled debt restructurings
Number of contracts | contract		2		3
Pre-modification outstanding recorded investment		$ 1,500		$ 1,825
Post-modification outstanding recorded investment		$ 1,444		$ 1,769
Public administration | Commercial
Troubled debt restructurings
Number of contracts | contract			1
Pre-modification outstanding recorded investment			$ 320
Post-modification outstanding recorded investment			$ 320
Commercial - Other | Commercial
Troubled debt restructurings
Number of contracts | contract	8	4	13	8
Pre-modification outstanding recorded investment	$ 4,617	$ 3,122	$ 14,472	$ 6,640
Post-modification outstanding recorded investment	$ 3,763	$ 2,757	$ 13,230	$ 5,726

Loans - Schedule of Troubled 49

Loans - Schedule of Troubled Debt Restructurings that Subsequently Defaulted (Details) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2017USD ($)item	Sep. 30, 2016USD ($)contract	Dec. 31, 2016USD ($)
Troubled debt restructurings that subsequently defaulted
Outstanding commitments on restructured loans	$ 2,500		$ 1,600
Number of loans restructured within the past 12 months that had a payment default | item	0
Commercial - Other | Commercial
Troubled debt restructurings that subsequently defaulted
Number of contracts | contract		3
Recorded investment		$ 1,586

Loans - Schedule of Nonaccrual

Loans - Schedule of Nonaccrual Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Nonaccrual loans
Total nonaccrual loans	$ 4,863	$ 2,638
Commercial
Nonaccrual loans
Total nonaccrual loans	4,418	2,202
Real estate - mortgage
Nonaccrual loans
Total nonaccrual loans	303	269
Consumer
Nonaccrual loans
Total nonaccrual loans	142	167
Manufacturing | Commercial
Nonaccrual loans
Total nonaccrual loans		2
Finance and insurance | Commercial
Nonaccrual loans
Total nonaccrual loans	19	25
Health care | Commercial
Nonaccrual loans
Total nonaccrual loans	304
Construction | Commercial
Nonaccrual loans
Total nonaccrual loans	1,006	234
Commercial - Other | Commercial
Nonaccrual loans
Total nonaccrual loans	3,089	1,941
Residential and commercial owner-occupied | Real estate - mortgage
Nonaccrual loans
Total nonaccrual loans	$ 303	$ 269

Loans - Schedule of Aging of Co

Loans - Schedule of Aging of Company's Loan Portfolio (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Nonaccrual loans
Total past due	$ 11,422	$ 5,771
Current	3,110,902	2,929,127
Total loans, excluding fees and costs	3,122,324	2,934,898
Unearned net loan fees	(626)	(793)
Total loans	3,121,698	2,934,105
Recorded investment in loans 90 days or more past due and accruing	20	657
30 - 59 Days past due
Nonaccrual loans
Total past due	4,806	4,365
60 - 89 Days past due
Nonaccrual loans
Total past due	5,023	649
90+ Days past due
Nonaccrual loans
Total past due	1,593	757
Commercial
Nonaccrual loans
Total past due	9,007	4,382
Current	1,241,250	1,212,619
Total loans, excluding fees and costs	1,250,257	1,217,001
Recorded investment in loans 90 days or more past due and accruing	20
Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	3,894	4,157
Commercial | 60 - 89 Days past due
Nonaccrual loans
Total past due	3,581	200
Commercial | 90+ Days past due
Nonaccrual loans
Total past due	1,532	25
Real estate - mortgage
Nonaccrual loans
Total past due	1,252	590
Current	1,258,396	1,171,006
Total loans, excluding fees and costs	1,259,648	1,171,596
Real estate - mortgage | 30 - 59 Days past due
Nonaccrual loans
Total past due	897	204
Real estate - mortgage | 60 - 89 Days past due
Nonaccrual loans
Total past due	355	386
Construction and land
Nonaccrual loans
Total past due		657
Current	216,737	175,081
Total loans, excluding fees and costs	216,737	175,738
Recorded investment in loans 90 days or more past due and accruing		657
Construction and land | 90+ Days past due
Nonaccrual loans
Total past due		657
Consumer
Nonaccrual loans
Total past due	1,163	142
Current	286,082	266,805
Total loans, excluding fees and costs	287,245	266,947
Consumer | 30 - 59 Days past due
Nonaccrual loans
Total past due	15	4
Consumer | 60 - 89 Days past due
Nonaccrual loans
Total past due	1,087	63
Consumer | 90+ Days past due
Nonaccrual loans
Total past due	61	75
Other
Nonaccrual loans
Current	108,437	103,616
Total loans, excluding fees and costs	108,437	103,616
Manufacturing | Commercial
Nonaccrual loans
Total past due	200
Current	89,774	96,618
Total loans, excluding fees and costs	89,974	96,618
Manufacturing | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	200
Finance and insurance | Commercial
Nonaccrual loans
Total past due	1,451	481
Current	38,505	49,870
Total loans, excluding fees and costs	39,956	50,351
Finance and insurance | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	1,451	456
Finance and insurance | Commercial | 90+ Days past due
Nonaccrual loans
Total past due		25
Health care | Commercial
Nonaccrual loans
Total past due	1,051	500
Current	151,634	153,523
Total loans, excluding fees and costs	152,685	154,023
Health care | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	459	500
Health care | Commercial | 60 - 89 Days past due
Nonaccrual loans
Total past due	459
Health care | Commercial | 90+ Days past due
Nonaccrual loans
Total past due	133
Real estate services | Commercial
Nonaccrual loans
Total past due	250
Current	120,564	126,044
Total loans, excluding fees and costs	120,814	126,044
Real estate services | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	250
Construction | Commercial
Nonaccrual loans
Total past due	813	260
Current	66,594	58,458
Total loans, excluding fees and costs	67,407	58,718
Construction | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	438	260
Construction | Commercial | 90+ Days past due
Nonaccrual loans
Total past due	375
Wholesale and retail trade | Commercial
Nonaccrual loans
Current	249,870	255,997
Total loans, excluding fees and costs	249,870	255,997
Commercial - Other | Commercial
Nonaccrual loans
Total past due	5,242	3,141
Current	524,309	472,109
Total loans, excluding fees and costs	529,551	475,250
Recorded investment in loans 90 days or more past due and accruing	20
Commercial - Other | Commercial | 30 - 59 Days past due
Nonaccrual loans
Total past due	1,096	2,941
Commercial - Other | Commercial | 60 - 89 Days past due
Nonaccrual loans
Total past due	3,122	200
Commercial - Other | Commercial | 90+ Days past due
Nonaccrual loans
Total past due	1,024
Residential and commercial owner-occupied | Real estate - mortgage
Nonaccrual loans
Total past due	127	365
Current	474,219	475,158
Total loans, excluding fees and costs	474,346	475,523
Residential and commercial owner-occupied | Real estate - mortgage | 30 - 59 Days past due
Nonaccrual loans
Total past due	5	204
Residential and commercial owner-occupied | Real estate - mortgage | 60 - 89 Days past due
Nonaccrual loans
Total past due	122	161
Residential and commercial investor | Real estate - mortgage
Nonaccrual loans
Total past due	1,125	225
Current	784,177	695,848
Total loans, excluding fees and costs	785,302	696,073
Residential and commercial investor | Real estate - mortgage | 30 - 59 Days past due
Nonaccrual loans
Total past due	892
Residential and commercial investor | Real estate - mortgage | 60 - 89 Days past due
Nonaccrual loans
Total past due	$ 233	$ 225

Accumulated Other Comprehensi52

Accumulated Other Comprehensive Income - Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Reclassifications from AOCI
Net loss on securities, other assets and other real estate owned			$ 307	$ 88
Interest on taxable / nontaxable securities	$ 36,947	$ 32,308	105,434	95,003
Interest and fees on loans	33,170	29,124	93,966	85,020
Interest on subordinated debentures and notes payable	(1,856)	(1,851)	(5,532)	(5,530)
Realized loss	15,312	13,812	38,985	35,256
Provision for income taxes	(4,119)	(3,543)	(9,689)	(9,090)
Total reclassifications out of AOCI	11,193	10,269	29,296	26,166
Reclassification out of AOCI
Reclassifications from AOCI
Total reclassifications out of AOCI	173	176	552	402
Reclassification out of AOCI | Cash flow hedges | Unrealized (gain) loss on derivatives
Reclassifications from AOCI
Interest and fees on loans	129	151	595	463
Interest on subordinated debentures and notes payable	(317)	(426)	(1,014)	(1,296)
Realized loss	(188)	(275)	(419)	(833)
Provision for income taxes	71	105	158	317
Total reclassifications out of AOCI	(117)	(170)	(261)	(516)
Reclassification out of AOCI | Available for sale securities | Unrealized (gain) loss on securities
Reclassifications from AOCI
Net loss on securities, other assets and other real estate owned	(2)	98	(5)	95
Provision for income taxes	1	(37)	2	(36)
Total reclassifications out of AOCI	(1)	61	(3)	59
Reclassification out of AOCI | Held to maturity securities | Unrealized (gain) loss on securities
Reclassifications from AOCI
Interest on taxable / nontaxable securities	469	459	1,313	1,385
Provision for income taxes	(178)	(174)	(497)	(526)
Total reclassifications out of AOCI	$ 291	$ 285	$ 816	$ 859

Accumulated Other Comprehensi53

Accumulated Other Comprehensive Income - AOCI rollforward (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Changes in AOCI
BALANCE - beginning of period			$ 302,310
Other comprehensive income (loss), net of tax	$ (367)	$ 570	1,180	$ (1,035)
BALANCE - end of period	329,090		329,090
Accumulated Comprehensive Income
Changes in AOCI
BALANCE - beginning of period			566
Other comprehensive income (loss) items			1,732
Reclassifications			(552)
Other comprehensive income (loss), net of tax			1,180
BALANCE - end of period	1,746		1,746
Unrealized (gain) loss on securities | Available for sale securities
Changes in AOCI
BALANCE - beginning of period			1,658
Other comprehensive income (loss) items			1,618
Reclassifications			3
Other comprehensive income (loss), net of tax			1,621
BALANCE - end of period	3,279		3,279
Unrealized (gain) loss on securities | Held to maturity securities
Changes in AOCI
BALANCE - beginning of period			3,154
Reclassifications			(816)
Other comprehensive income (loss), net of tax			(816)
BALANCE - end of period	2,338		2,338
Unrealized (gain) loss on derivatives
Changes in AOCI
BALANCE - beginning of period			(4,246)
Other comprehensive income (loss) items			114
Reclassifications			261
Other comprehensive income (loss), net of tax			375
BALANCE - end of period	$ (3,871)		$ (3,871)

Derivatives - Narrative (Detail

Derivatives - Narrative (Details) $ in Millions	1 Months Ended	3 Months Ended			9 Months Ended
	Oct. 31, 2016USD ($)contract	Sep. 30, 2017USD ($)derivative	Sep. 30, 2016USD ($)	Mar. 31, 2016USD ($)derivative	Sep. 30, 2017USD ($)derivative	Sep. 30, 2016USD ($)
Cash flow, Fair value, and non-designated hedges
Fair value of derivatives in a net liability position		$ 8.4			$ 8.4
Collateral already posted		8.6			8.6
Interest Income
Cash flow, Fair value, and non-designated hedges
Period of reclassification				3 years
Estimated gains (losses) to be reclassified as earnings in next 12 months		0.1			0.1
Interest Expense
Cash flow, Fair value, and non-designated hedges
Estimated gains (losses) to be reclassified as earnings in next 12 months		1.1			1.1
Other Income | Fair value hedges
Cash flow, Fair value, and non-designated hedges
Net amount recognized for hedge ineffectiveness						$ 0.3
Derivatives designated as hedging instruments | Interest rate swap | Cash flow hedges | Variable rate loan assets
Cash flow, Fair value, and non-designated hedges
Number of interest rate swaps terminated | derivative				5
Notional amount of derivative instrument	$ 100			$ 75
Unrealized gain on derivatives					1.3
Number of derivative contracts entered | contract	2
Weighted average term	5 years
Fixed rate	1.20%
Derivatives designated as hedging instruments | Interest rate swap | Fair value hedges
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument		$ 60.5			$ 60.5
Number of interest-rate swaps held | derivative		11			11
Derivatives not designated as hedging instruments
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument		$ 259.3			$ 259.3
Derivatives not designated as hedging instruments | Other Income
Cash flow, Fair value, and non-designated hedges
Net gains recognized on derivative		$ 0.2			$ 0.5
Derivatives not designated as hedging instruments | Interest rate swap
Cash flow, Fair value, and non-designated hedges
Number of interest-rate swaps held | derivative		100			100
Derivatives not designated as hedging instruments | Foreign exchange forward contracts
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument		$ 4.9			$ 4.9
Net gains recognized on derivative			$ 0.1			$ 0.3

Derivatives - Schedule of Deriv

Derivatives - Schedule of Derivatives Instruments in Statements of Financial Position (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Derivatives designated as hedging instruments | Interest rate swap | Other assets | Fair value hedges
Derivatives at fair value
Asset derivatives, designated as hedging at Fair value	$ 400	$ 476
Derivatives designated as hedging instruments | Interest rate swap | Accrued interest and other liabilities | Cash flow hedges
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	6,584	7,639
Derivatives designated as hedging instruments | Interest rate swap | Accrued interest and other liabilities | Fair value hedges
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	920	845
Derivatives not designated as hedging instruments | Interest rate swap | Other assets
Derivatives at fair value
Asset derivatives, designated as hedging at Fair value	2,255	2,755
Derivatives not designated as hedging instruments | Interest rate swap | Accrued interest and other liabilities
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	2,349	2,736
Derivatives not designated as hedging instruments | Foreign exchange forward contracts | Other assets
Derivatives at fair value
Asset derivatives, not designated as hedging at Fair value	23	52
Derivatives not designated as hedging instruments | Foreign exchange forward contracts | Accrued interest and other liabilities
Derivatives at fair value
Liability derivatives, not designated as hedging at Fair value	$ 4	$ 5

Derivatives - Schedule of Fair

Derivatives - Schedule of Fair Value of Derivative Financial Instruments and Classification on Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Derivative assets, net
Gross amounts of recognized assets	$ 2,678	$ 3,283
Net amounts included in other assets in the Condensed Consolidated Balance Sheets	2,678	3,283
Gross amounts not offset - Financial instruments	(1,235)	(1,443)
Gross amounts not offset - Net Amount	1,443	1,840
Securities sold under agreements to repurchase
Gross amounts of recognized liabilities	(60,335)	(27,639)
Net amounts included in accrued interest and other liabilities in the Consolidated Balance Sheets	(60,335)	(27,639)
Gross amounts not offset - Collateral	60,335	27,639
Total offsetting derivative liabilities and securities sold under agreements to repurchase
Gross amounts of recognized liabilities	(70,192)	(38,864)
Net amounts included in accrued interest and other liabilities in the Consolidated Balance Sheets	(70,192)	(38,864)
Gross amounts not offset - Financial instruments	1,235	1,443
Gross amounts not offset - Collateral	68,891	37,315
Gross amounts not offset - Net Amount	(66)	(106)
Derivatives designated as hedging instruments
Derivative assets, net
Gross amounts of recognized assets	400	476
Net amounts included in other assets in the Condensed Consolidated Balance Sheets	400	476
Gross amounts not offset - Financial instruments	(400)	(476)
Derivatives designated as hedges or not designated as hedges
Gross amounts of recognized liabilities	(7,504)	(8,484)
Net amounts included in accrued interest and other liabilities' in the condensed consolidated balance sheets	(7,504)	(8,484)
Gross amounts not offset - Financial instruments	400	476
Gross amounts not offset - Collateral	7,104	8,008
Derivatives not designated as hedging instruments
Derivative assets, net
Gross amounts of recognized assets	2,278	2,807
Net amounts included in other assets in the Condensed Consolidated Balance Sheets	2,278	2,807
Gross amounts not offset - Financial instruments	(835)	(967)
Gross amounts not offset - Net Amount	1,443	1,840
Derivatives designated as hedges or not designated as hedges
Gross amounts of recognized liabilities	(2,353)	(2,741)
Net amounts included in accrued interest and other liabilities' in the condensed consolidated balance sheets	(2,353)	(2,741)
Gross amounts not offset - Financial instruments	835	967
Gross amounts not offset - Collateral	1,452	1,668
Gross amounts not offset - Net Amount	$ (66)	$ (106)

Derivatives - Schedule of Notio

Derivatives - Schedule of Notional Amounts of Outstanding Derivative Positions (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2017USD ($)
CoBiz Statutory Trust I
Derivatives, statutory trusts
Notional amount of derivative instrument	$ 20,000
Fixed rate	4.99%
Termination date	Mar. 17, 2022
CoBiz Capital Trust II
Derivatives, statutory trusts
Notional amount of derivative instrument	$ 30,000
Fixed rate	5.99%
Termination date	Apr. 23, 2020
CoBiz Capital Trust III
Derivatives, statutory trusts
Notional amount of derivative instrument	$ 20,000
Fixed rate	5.02%
Termination date	Mar. 30, 2024

Borrowed Funds - Schedule of Se

Borrowed Funds - Schedule of Securities Sold Under Agreements to Repurchase (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2017USD ($)Counterparty	Dec. 31, 2016USD ($)
Securities sold under agreements to repurchase
Securities sold under agreements to repurchase	$ 60,335,000	$ 27,639,000
Other short-term borrowings	101,476,000	106,230,000
Securities Sold under Agreements to Repurchase
Securities sold under agreements to repurchase
Securities sold under agreements to repurchase	60,335,000	27,639,000
Fair value of securities sold under agreements to repurchase	61,542,000	28,192,000
Short-term debt, average outstanding amount	59,800,000	46,000,000
Short-term debt, maximum amount outstanding at any month end	$ 69,900,000	$ 71,000,000
Short-term debt, weighted average interest rate	0.06%	0.07%
Other Short-Term Borrowings
Securities sold under agreements to repurchase
Other short-term borrowings	$ 101,476,000	$ 106,230,000
Fair value of securities sold under agreements to repurchase	588,900,000	598,500,000
Pledged loans	851,700,000	861,000,000
Average balance	$ 133,000,000	$ 82,800,000
Variable rate basis	1.28%	0.72%
Revolving Line of Credit (LOC)
Securities sold under agreements to repurchase
Maximum borrowing capacity	$ 20,000,000
Commitment fee percentage on the unused portion of the LOC	0.35%
Amount outstanding	$ 0	$ 0
Federal Fund Purchase Lines
Securities sold under agreements to repurchase
Short-term debt, average outstanding amount	1,600,000	2,000,000
Maximum borrowing capacity	180,000,000
Amount outstanding	$ 1,500,000	$ 0
Number of banks providing line of credit | Counterparty	8
Federal Reserve Bank of Kansas Through The Discount Window Lending Program
Securities sold under agreements to repurchase
Pledged loans	$ 817,100,000
1-month LIBOR | Revolving Line of Credit (LOC)
Securities sold under agreements to repurchase
Basis spread on variable rate	2.25%

Employee Benefit and Stock Co59

Employee Benefit and Stock Compensation Plans - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2017
Employee Benefit and Stock Compensation Plans
Share-based compensation expense	$ 0.7	$ 2.6

Employee Benefit and Stock Co60

Employee Benefit and Stock Compensation Plans - Summary of Changes in Stock Option Awards (Details)	9 Months Ended
	Sep. 30, 2017$ / sharesshares
Employee Benefit and Stock Compensation Plans
Shares, Outstanding - beginning of year | shares	285,999
Shares, Granted | shares	34,500
Shares, Exercised | shares	(96,703)
Shares, Forfeited | shares	(15,200)
Shares, Outstanding - end of year | shares	208,596
Shares, Exercisable - end of year | shares	112,952
Weighted average exercise price, Outstanding - beginning of year	$ 10.45
Weighted average exercise price, Granted	16.94
Weighted average exercise price, Exercised	9.80
Weighted average exercise price, Forfeited	11.99
Weighted average exercise price, Outstanding - end of year	11.71
Weighted average exercise price, Exercisable - end of year	10.10
Weighted average grant date fair value of options granted	$ 3.42

Employee Benefit and Stock Co61

Employee Benefit and Stock Compensation Plans - Summary of Changes in Stock Awards (Details) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2017USD ($)$ / sharesshares
Employee Benefit and Stock Compensation Plans
Shares, Unvested - beginning of year | shares	467,203
Shares, Granted | shares	199,146
Shares, Vested | shares	(253,407)
Shares, Forfeited | shares	(8,036)
Shares, Unvested - end of year | shares	404,906
Weighted average grant date fair value, Unvested - beginning of year | $ / shares	$ 11.50
Weighted average grant date fair value, Granted | $ / shares	16.99
Weighted average grant date fair value, Vested | $ / shares	11.93
Weighted average grant date fair value, Forfeited | $ / shares	12.81
Weighted average grant date fair value, Unvested - end of year | $ / shares	$ 13.90
Total unrecognized compensation expense related to unvested share-based compensation arrangements granted under equity incentive plans | $	$ 4.3
Unrecognized compensation expense related to unvested share-based compensation arrangements, expected weighted average recognition period, years	1 year 10 months 24 days

Segments - Summary of Results O

Segments - Summary of Results Of Operations by Operating Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Segments
Total interest income	$ 36,947	$ 32,308	$ 105,434	$ 95,003
Total interest expense	3,178	2,907	9,582	8,840
Provision for loan losses	1,060	(1,168)	2,340	(2,450)
Noninterest income	8,995	9,286	25,634	24,786
Noninterest expense	26,392	26,043	80,161	78,143
Provision (benefit) for income taxes	4,119	3,543	9,689	9,090
Net income (loss)	11,193	10,269	29,296	26,166
Commercial Banking
Segments
Total interest income	36,862	32,216	105,176	94,727
Total interest expense	1,327	1,078	4,085	3,369
Provision for loan losses	1,098	(1,158)	2,472	(2,300)
Noninterest income	3,777	3,622	10,447	9,318
Noninterest expense	8,658	9,731	26,222	27,715
Management fees and allocations, net of tax	7,881	7,757	23,930	23,831
Provision (benefit) for income taxes	9,661	7,535	26,423	21,888
Net income (loss)	12,014	10,895	32,491	29,542
Fee-Based Lines
Segments
Total interest income			1	1
Total interest expense	(1)	11	13	25
Noninterest income	4,888	4,536	14,468	13,578
Noninterest expense	4,237	4,055	13,003	12,807
Management fees and allocations, net of tax	290	464	882	1,255
Provision (benefit) for income taxes	239	165	511	277
Net income (loss)	123	(159)	60	(785)
Corporate Support and Other
Segments
Total interest income	85	92	257	275
Total interest expense	1,852	1,818	5,484	5,446
Provision for loan losses	(38)	(10)	(132)	(150)
Noninterest income	330	1,128	719	1,890
Noninterest expense	13,497	12,257	40,936	37,621
Management fees and allocations, net of tax	(8,171)	(8,221)	(24,812)	(25,086)
Provision (benefit) for income taxes	(5,781)	(4,157)	(17,245)	(13,075)
Net income (loss)	$ (944)	$ (467)	$ (3,255)	$ (2,591)

Fair Value Measurements - Finan

Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Assets and liabilities measured at fair value
Investment securities available for sale	$ 177,591	$ 132,981
Total derivative assets	2,678	3,283
Trust preferred securities
Assets and liabilities measured at fair value
Investment securities available for sale	38,691	37,624
Corporate debt securities
Assets and liabilities measured at fair value
Investment securities available for sale	135,590	92,077
Derivatives designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets	400	476
Total derivative liabilities	7,504	8,484
Derivatives not designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets	2,278	2,807
Total derivative liabilities	2,353	2,741
Recurring
Assets and liabilities measured at fair value
Investment securities available for sale	177,591	132,981
Total derivative assets	2,678	3,283
Total derivative liabilities	9,857	11,225
Recurring | Quoted prices in active markets for identical assets (Level 1)
Assets and liabilities measured at fair value
Investment securities available for sale	4,433	4,283
Recurring | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	163,991	119,250
Total derivative assets	2,678	3,283
Total derivative liabilities	9,857	11,225
Recurring | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Investment securities available for sale	9,167	9,448
Recurring | Trust preferred securities
Assets and liabilities measured at fair value
Investment securities available for sale	38,691	37,624
Recurring | Trust preferred securities | Quoted prices in active markets for identical assets (Level 1)
Assets and liabilities measured at fair value
Investment securities available for sale	4,433	4,283
Recurring | Trust preferred securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	25,091	23,893
Recurring | Trust preferred securities | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Investment securities available for sale	9,167	9,448
Recurring | Corporate debt securities
Assets and liabilities measured at fair value
Investment securities available for sale	135,590	92,077
Recurring | Corporate debt securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	135,590	92,077
Recurring | Municipal securities
Assets and liabilities measured at fair value
Investment securities available for sale	3,310	3,280
Recurring | Municipal securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	3,310	3,280
Recurring | Foreign exchange forward contracts
Assets and liabilities measured at fair value
Total derivative assets	23	52
Total derivative liabilities	4	5
Recurring | Foreign exchange forward contracts | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Total derivative assets	23	52
Total derivative liabilities	4	5
Recurring | Derivatives designated as hedging instruments | Cash flow hedges
Assets and liabilities measured at fair value
Total derivative liabilities	6,584	7,639
Recurring | Derivatives designated as hedging instruments | Fair value hedges
Assets and liabilities measured at fair value
Total derivative assets	400	476
Total derivative liabilities	920	845
Recurring | Derivatives designated as hedging instruments | Significant other observable inputs (Level 2) | Cash flow hedges
Assets and liabilities measured at fair value
Total derivative liabilities	6,584	7,639
Recurring | Derivatives designated as hedging instruments | Significant other observable inputs (Level 2) | Fair value hedges
Assets and liabilities measured at fair value
Total derivative assets	400	476
Total derivative liabilities	920	845
Recurring | Derivatives not designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets	2,255	2,755
Total derivative liabilities	2,349	2,736
Recurring | Derivatives not designated as hedging instruments | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Total derivative assets	2,255	2,755
Total derivative liabilities	$ 2,349	$ 2,736

Fair Value Measurements - Recon

Fair Value Measurements - Reconciliation of the Beginning and Ending Balance of Financial Assets Measured At Fair Value On Recurring Basis Using Level 3 Inputs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Reconciliation of Level 3 inputs
Beginning balance	$ 10,198	$ 8,955	$ 9,448	$ 5,810
Transfers and purchases				3,276
Net accretion	28	29	87	60
Sales/calls/maturities	(1,000)		(1,000)
Unrealized gain (loss) included in comprehensive income	(59)	291	632	129
Ending balance	$ 9,167	$ 9,275	$ 9,167	$ 9,275

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Nonrecurring Basis (OREO and Impaired Loans) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Assets and liabilities measured at fair value
OREO recorded at fair value	$ 5,351		$ 5,351		$ 5,351
Provision for loan losses			2,340	$ (2,450)
OREO
Assets and liabilities measured at fair value
OREO recorded at fair value	5,351		5,351		5,351
Impaired Loans
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	2,969		2,969		1,425
Provision for loan losses	38	$ 975	1,009	$ 3,149
Nonrecurring | OREO
Assets and liabilities measured at fair value
OREO recorded at fair value	5,351		5,351		5,351
Nonrecurring | OREO | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
OREO recorded at fair value	5,351		5,351		5,351
Nonrecurring | Impaired Loans
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	2,969		2,969		1,425
Nonrecurring | Impaired Loans | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	$ 2,969		$ 2,969		$ 1,425

Fair Value Measurements - Sch66

Fair Value Measurements - Schedule of Reconciliation of Fair Value Measurement of Other Real Estate Owned (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Fair Value Measurements
OREO recorded at fair value	$ 5,351	$ 5,351
Estimated selling costs	(272)	(272)
OREO	$ 5,079	$ 5,079

Fair Value Measurements - Sch67

Fair Value Measurements - Schedule of Valuation Process Used to Determine Fair Value Measurement within Level 3 (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Fair value valuation processes
Investment securities available for sale	$ 177,591	$ 132,981
OREO recorded at fair value	5,351	5,351
Impaired Loans
Fair value valuation processes
Impaired loans	2,969	1,425
OREO
Fair value valuation processes
OREO recorded at fair value	5,351	5,351
Market approach | Trust preferred securities
Fair value valuation processes
Investment securities available for sale	$ 9,167	$ 9,448
Valuation technique	Market approach	Market approach
Unobservable input	Discount to carrying value using broker quotes or observable prices on similar securities	Discount to carrying value using broker quotes or observable prices on similar securities
Market approach | Weighted average | Trust preferred securities
Fair value valuation processes
Discount rate	7.00%	13.00%
Market approach | Minimum | Trust preferred securities
Fair value valuation processes
Discount rate	5.00%	1.00%
Market approach | Maximum | Trust preferred securities
Fair value valuation processes
Discount rate	13.00%	28.00%
Commercial | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 2,509	$ 1,057
Valuation technique	Sales comparison (1)	Sales comparison (1)
Unobservable input	Management discount for asset type	Management discount for asset type
Commercial | Sales comparison | Weighted average | Impaired Loans
Fair value valuation processes
Discount rate	53.00%	59.00%
Commercial | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Discount rate	0.00%	76.00%
Commercial | Sales comparison | Maximum | Impaired Loans
Fair value valuation processes
Discount rate	90.00%	0.00%
Commercial | Property appraisals | OREO
Fair value valuation processes
OREO recorded at fair value	$ 190	$ 190
Valuation technique	Property appraisals (2)	Property appraisals (2)
Unobservable input	Management discount for property type	Management discount for property type
Discount rate		0.00%
Commercial | Property appraisals | Weighted average | OREO
Fair value valuation processes
Discount rate	0.00%	0.00%
Real estate - mortgage | Maximum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(4.00%)
Real estate - mortgage | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 303	$ 269
Valuation technique	Sales comparison (2)	Sales comparison (2)
Unobservable input	Sales comparison adjustments	Sales comparison adjustments
Real estate - mortgage | Sales comparison | Weighted average | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(2.00%)	18.00%
Real estate - mortgage | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(1.00%)
Construction and land | Property appraisals | OREO
Fair value valuation processes
OREO recorded at fair value	$ 5,161	$ 5,161
Valuation technique	Property appraisals (2)	Property appraisals (2)
Unobservable input	Management discount for property type	Management discount for property type
Construction and land | Property appraisals | Weighted average | OREO
Fair value valuation processes
Discount rate	17.00%	17.00%
Consumer | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 157	$ 99
Valuation technique	Sales comparison (2)	Sales comparison (2)
Unobservable input	Sales comparison adjustments	Sales comparison adjustments
Consumer | Sales comparison | Weighted average | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(36.00%)	(1.00%)
Consumer | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments		(11.00%)
Consumer | Sales comparison | Maximum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments		10.00%
Consumer | Property appraisals | Minimum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(13.00%)
Consumer | Property appraisals | Maximum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(59.00%)

Fair Value Measurements - Sch68

Fair Value Measurements - Schedule of Estimated Fair Value of Other Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015
Fair value of financial instruments
Cash and cash equivalents	$ 79,305	$ 96,050	$ 86,148	$ 67,312
Investment securities available for sale	177,591	132,981
Investment securities held to maturity	360,935	366,041
Other investments	11,222	11,365
Loans - net	3,084,848	2,900,812
Accrued interest receivable	13,698	12,223
Derivatives assets	2,678	3,283
Deposits	3,177,532	3,029,783
Securities sold under agreements to repurchase	60,335	27,639
Other short-term borrowings	101,476	106,230
Subordinated notes payable	59,173	59,111
Junior subordinated debentures	72,166	72,166
Carrying Value
Fair value of financial instruments
Cash and cash equivalents	79,305	96,050
Investment securities available for sale	177,591	132,981
Investment securities held to maturity	360,935	366,041
Other investments	2,174	2,173
Loans - net	3,084,848	2,900,812
Accrued interest receivable	13,698	12,223
Derivatives assets	2,678	3,283
Deposits	3,177,532	3,029,783
Securities sold under agreements to repurchase	60,335	27,639
Other short-term borrowings	101,476	106,230
Accrued interest payable	1,876	1,038
Subordinated notes payable	59,173	59,111
Junior subordinated debentures	72,166	72,166
Derivatives liabilities	9,857	11,225
Total Fair Value
Fair value of financial instruments
Cash and cash equivalents	79,305	96,050
Investment securities available for sale	177,591	132,981
Investment securities held to maturity	360,380	363,178
Other investments	2,174	2,173
Loans - net	3,080,579	2,868,091
Accrued interest receivable	13,698	12,223
Derivatives assets	2,678	3,283
Deposits	3,176,777	3,029,226
Securities sold under agreements to repurchase	56,667	26,101
Other short-term borrowings	101,476	106,230
Accrued interest payable	1,876	1,038
Subordinated notes payable	58,983	58,681
Junior subordinated debentures	72,166	72,166
Derivatives liabilities	$ 9,857	$ 11,225

Regulatory Matters - Schedule o

Regulatory Matters - Schedule of Regulatory Capital Amounts and Ratios of Company and Bank (Details)	9 Months Ended
	Sep. 30, 2017
Regulatory matters
Minimum Capital Conservation Buffer (as percent)	1.25%
Annual increase in minimum Capital Conservation Buffer (as percent)	0.625%
Increased Capital Conservation Buffer (as percent)	2.50%
Common Tier 1, Risk-based, Capital ratios (as a percent)	10.00%
Common Tier 1, Risk-based, Well-capitalized requirement (as a percent)	6.50%
Common Tier 1, Risk-based, Minimum capital requirement (as a percent)	7.00%
Tier I, Risk-based, Capital ratios (as a percent)	11.60%
Tier I, Risk-based, Well-capitalized requirement (as a percent)	8.00%
Tier I, Risk-based, Minimum capital requirement (as a percent)	8.50%
Total capital, Risk-based, Capital ratios (as a percent)	14.50%
Total capital, Risk-based, Well-capitalized requirement (as a percent)	10.00%
Total capital, Risk-based, Minimum capital requirement (as a percent)	10.50%
Tier I, Leverage, Capital ratios (as a percent)	10.00%
Tier I, Leverage, Well-capitalized requirement (as a percent)	5.00%
Tier I, Leverage, Minimum capital requirement (as a percent)	4.00%
Bank
Regulatory matters
Common Tier 1, Risk-based, Capital ratios (as a percent)	12.00%
Tier I, Risk-based, Capital ratios (as a percent)	12.00%
Total capital, Risk-based, Capital ratios (as a percent)	13.10%
Tier I, Leverage, Capital ratios (as a percent)	10.40%

Supplemental Financial Data (De

Supplemental Financial Data (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Other noninterest income
Loan fees	$ 953	$ 795	$ 1,816	$ 1,737
Other customer service fees	741	694	2,163	2,023
Bank-owned life insurance	356	345	1,015	1,000
Other Investments	355	1,348	1,102	2,262
Derivative Valuation	(35)		(172)	(456)
Other	77	15	123	134
Total	2,447	3,197	6,047	6,700
Other noninterest expense
Marketing and business development	603	559	1,991	2,104
Service contracts	1,374	1,331	4,095	3,855
Professional fees	923	824	2,621	2,135
Office supplies and delivery	313	336	894	972
Other	540	947	2,408	2,861
Total	$ 3,753	$ 3,997	$ 12,009	$ 11,927